+Follow
欣欣宇
No personal profile
11
Follow
4
Followers
0
Topic
0
Badge
Posts
Hot
欣欣宇
2021-09-21
$Vanguard S&P 500 ETF(VOO)$
?
欣欣宇
2021-07-22
$ARK Genomic Revolution Multi-Sector ETF(ARKG)$
._. Have been holding since last year
欣欣宇
2021-07-09
Nice
China June new bank loans rise to 2.12 trln yuan, beat expectations
欣欣宇
2021-07-09
Oh noooo
Hong Kong stocks post worst week in over 4 months on tech rout
欣欣宇
2021-07-09
Kkkk
GameStop Short Seller Melvin Capital Ended 2021 First-Half With 46% Loss: Report
欣欣宇
2021-07-09
Good
China cuts reserve requirements to support economic recovery
欣欣宇
2021-07-06
$Alibaba(BABA)$
Fml
欣欣宇
2021-07-02
$Alibaba(BABA)$
Sobs
欣欣宇
2021-07-02
$ARK Genomic Revolution Multi-Sector ETF(ARKG)$
Have been holding since Feb
欣欣宇
2021-06-26
$ARK Genomic Revolution Multi-Sector ETF(ARKG)$
LOLOL finally less than 10%
欣欣宇
2021-06-26
Wow
Sorry, the original content has been removed
欣欣宇
2021-04-30
Nice
Sorry, the original content has been removed
欣欣宇
2021-04-30
Nice
Amazon once rose 2.4%, setting a record high in intraday trading
欣欣宇
2021-04-30
Nice
Joe Biden's $6 trillion ambition
欣欣宇
2021-04-30
Nice
3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street
欣欣宇
2021-04-30
Nice
NIO rose more than 5%, after falling nearly 4% before
欣欣宇
2021-04-29
$ARK Genomic Revolution Multi-Sector ETF(ARKG)$
wth is wrong w this
欣欣宇
2021-04-28
$ARK Genomic Revolution Multi-Sector ETF(ARKG)$
-.-
欣欣宇
2021-04-24
$ARK Genomic Revolution Multi-Sector ETF(ARKG)$
I am worried
欣欣宇
2021-04-24
$ARK Innovation ETF(ARKK)$
Waiting for it to recover
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3560508329513236","uuid":"3560508329513236","gmtCreate":1611969546616,"gmtModify":1706620736990,"name":"欣欣宇","pinyin":"xxyxinxinyu","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":11,"tweetSize":26,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.85%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.04","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.85%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":869909710,"gmtCreate":1632232781030,"gmtModify":1676530730510,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VOO\">$Vanguard S&P 500 ETF(VOO)$</a>?","listText":"<a href=\"https://laohu8.com/S/VOO\">$Vanguard S&P 500 ETF(VOO)$</a>?","text":"$Vanguard S&P 500 ETF(VOO)$?","images":[{"img":"https://static.tigerbbs.com/3f37c53f199580d28bc2cf8dd6a9a33a","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/869909710","isVote":1,"tweetType":1,"viewCount":1754,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":172289826,"gmtCreate":1626962452465,"gmtModify":1703481468254,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>._. Have been holding since last year ","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>._. Have been holding since last year ","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$._. Have been holding since last year","images":[{"img":"https://static.tigerbbs.com/c807337cb85ef61d9bcd70f1b3161ee3","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172289826","isVote":1,"tweetType":1,"viewCount":2101,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":141977194,"gmtCreate":1625837339818,"gmtModify":1703749531267,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"Nice ","listText":"Nice ","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141977194","repostId":"2150376848","repostType":4,"repost":{"id":"2150376848","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1625821544,"share":"https://ttm.financial/m/news/2150376848?lang=en_US&edition=fundamental","pubTime":"2021-07-09 17:05","market":"hk","language":"en","title":"China June new bank loans rise to 2.12 trln yuan, beat expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2150376848","media":"Reuters","summary":"BEIJING, July 9 (Reuters) - Chinese banks extended 2.12 trillion yuan ($327 billion) in new yuan loa","content":"<p>BEIJING, July 9 (Reuters) - Chinese banks extended 2.12 trillion yuan ($327 billion) in new yuan loans in June, up from May and exceeding analysts' expectations.</p>\n<p>Analysts polled by Reuters had predicted new yuan loans would rise to 1.8 trillion yuan in June from 1.5 trillion yuan the previous month and against 1.81 trillion yuan a year earlier.</p>\n<p>Broad M2 money supply grew 8.6% from a year earlier, central bank data showed on Friday, also above estimates of 8.2% forecast in the Reuters poll. M2 grew 8.3% in May from a year ago.</p>\n<p>Outstanding yuan loans grew 12.3% from a year earlier compared with 12.2% growth in May. Analysts had expected 12.1% growth.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China June new bank loans rise to 2.12 trln yuan, beat expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina June new bank loans rise to 2.12 trln yuan, beat expectations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-09 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BEIJING, July 9 (Reuters) - Chinese banks extended 2.12 trillion yuan ($327 billion) in new yuan loans in June, up from May and exceeding analysts' expectations.</p>\n<p>Analysts polled by Reuters had predicted new yuan loans would rise to 1.8 trillion yuan in June from 1.5 trillion yuan the previous month and against 1.81 trillion yuan a year earlier.</p>\n<p>Broad M2 money supply grew 8.6% from a year earlier, central bank data showed on Friday, also above estimates of 8.2% forecast in the Reuters poll. M2 grew 8.3% in May from a year ago.</p>\n<p>Outstanding yuan loans grew 12.3% from a year earlier compared with 12.2% growth in May. Analysts had expected 12.1% growth.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CAAS":"中汽系统"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2150376848","content_text":"BEIJING, July 9 (Reuters) - Chinese banks extended 2.12 trillion yuan ($327 billion) in new yuan loans in June, up from May and exceeding analysts' expectations.\nAnalysts polled by Reuters had predicted new yuan loans would rise to 1.8 trillion yuan in June from 1.5 trillion yuan the previous month and against 1.81 trillion yuan a year earlier.\nBroad M2 money supply grew 8.6% from a year earlier, central bank data showed on Friday, also above estimates of 8.2% forecast in the Reuters poll. M2 grew 8.3% in May from a year ago.\nOutstanding yuan loans grew 12.3% from a year earlier compared with 12.2% growth in May. Analysts had expected 12.1% growth.","news_type":1,"symbols_score_info":{"CAAS":0.9}},"isVote":1,"tweetType":1,"viewCount":1801,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":141977009,"gmtCreate":1625837311701,"gmtModify":1703749530451,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"Oh noooo","listText":"Oh noooo","text":"Oh noooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141977009","repostId":"2150537517","repostType":4,"repost":{"id":"2150537517","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1625821315,"share":"https://ttm.financial/m/news/2150537517?lang=en_US&edition=fundamental","pubTime":"2021-07-09 17:01","market":"hk","language":"en","title":"Hong Kong stocks post worst week in over 4 months on tech rout","url":"https://stock-news.laohu8.com/highlight/detail?id=2150537517","media":"Reuters","summary":"* HK->Shanghai Connect daily quota used 2.9%, Shanghai->HK daily quota used 6.9%\n* HSI +0.7%, HSCE +","content":"<p>* HK->Shanghai Connect daily quota used 2.9%, Shanghai->HK daily quota used 6.9%</p>\n<p>* HSI +0.7%, HSCE +0.6%, CSI300 -0.4%</p>\n<p>* FTSE China A50 -0.6%</p>\n<p>July 9 (Reuters) - Hong Kong stocks rose on Friday after eight straight sessions of falls, but marked their worst week in more than four months due to a tech rout fuelled by regulatory concerns.</p>\n<p>** The Hang Seng index rose 0.7% to 27,344.54, while the China Enterprises Index gained 0.6% to 9,885.42.</p>\n<p>** For the week, HSI dropped 3.4% and HSCE slumped 5.1%, both posting their worst week since late February.</p>\n<p>** The Hang Seng tech index hit a nine-month low before reversing course to end 1.5% higher, helped by bargain hunting.</p>\n<p>** The index has tumbled more than 30% from a record high hit in mid-February, as Beijing stepped up regulatory pressure on the country's tech giants and platform companies.</p>\n<p>** China's securities regulator is setting up a team to review plans by Chinese companies for initial public offerings (IPOs) abroad.</p>\n<p>** On Wednesday, China's market regulator said it had fined a number of internet companies including Didi Chuxing , Tencent and Alibaba for failing to report earlier merger and acquisition deals for approval.</p>\n<p>** That came after China's cyberspace regulator said on Sunday that it had ordered smartphone app stores to stop offering Didi Global Inc's app after finding that the ride-hailing giant had illegally collected users' personal data.</p>\n<p>** Also weighing on sentiment were the latest headlines on Sino-U.S. tensions.</p>\n<p>** The Biden administration is set as early as Friday to add more than 10 Chinese companies to its economic blacklist over alleged human rights abuses and high-tech surveillance in Xinjiang, two sources told Reuters.</p>\n<p>** Late on Wednesday, the S&P Dow Jones Indices and FTSE Russell decided to remove more Chinese companies from their indices after an updated U.S. executive order barred domestic investment in firms with alleged ties to China's military.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong stocks post worst week in over 4 months on tech rout</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong stocks post worst week in over 4 months on tech rout\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-09 17:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* HK->Shanghai Connect daily quota used 2.9%, Shanghai->HK daily quota used 6.9%</p>\n<p>* HSI +0.7%, HSCE +0.6%, CSI300 -0.4%</p>\n<p>* FTSE China A50 -0.6%</p>\n<p>July 9 (Reuters) - Hong Kong stocks rose on Friday after eight straight sessions of falls, but marked their worst week in more than four months due to a tech rout fuelled by regulatory concerns.</p>\n<p>** The Hang Seng index rose 0.7% to 27,344.54, while the China Enterprises Index gained 0.6% to 9,885.42.</p>\n<p>** For the week, HSI dropped 3.4% and HSCE slumped 5.1%, both posting their worst week since late February.</p>\n<p>** The Hang Seng tech index hit a nine-month low before reversing course to end 1.5% higher, helped by bargain hunting.</p>\n<p>** The index has tumbled more than 30% from a record high hit in mid-February, as Beijing stepped up regulatory pressure on the country's tech giants and platform companies.</p>\n<p>** China's securities regulator is setting up a team to review plans by Chinese companies for initial public offerings (IPOs) abroad.</p>\n<p>** On Wednesday, China's market regulator said it had fined a number of internet companies including Didi Chuxing , Tencent and Alibaba for failing to report earlier merger and acquisition deals for approval.</p>\n<p>** That came after China's cyberspace regulator said on Sunday that it had ordered smartphone app stores to stop offering Didi Global Inc's app after finding that the ride-hailing giant had illegally collected users' personal data.</p>\n<p>** Also weighing on sentiment were the latest headlines on Sino-U.S. tensions.</p>\n<p>** The Biden administration is set as early as Friday to add more than 10 Chinese companies to its economic blacklist over alleged human rights abuses and high-tech surveillance in Xinjiang, two sources told Reuters.</p>\n<p>** Late on Wednesday, the S&P Dow Jones Indices and FTSE Russell decided to remove more Chinese companies from their indices after an updated U.S. executive order barred domestic investment in firms with alleged ties to China's military.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QNETCN":"纳斯达克中美互联网老虎指数","09988":"阿里巴巴-W","HSI":"恒生指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2150537517","content_text":"* HK->Shanghai Connect daily quota used 2.9%, Shanghai->HK daily quota used 6.9%\n* HSI +0.7%, HSCE +0.6%, CSI300 -0.4%\n* FTSE China A50 -0.6%\nJuly 9 (Reuters) - Hong Kong stocks rose on Friday after eight straight sessions of falls, but marked their worst week in more than four months due to a tech rout fuelled by regulatory concerns.\n** The Hang Seng index rose 0.7% to 27,344.54, while the China Enterprises Index gained 0.6% to 9,885.42.\n** For the week, HSI dropped 3.4% and HSCE slumped 5.1%, both posting their worst week since late February.\n** The Hang Seng tech index hit a nine-month low before reversing course to end 1.5% higher, helped by bargain hunting.\n** The index has tumbled more than 30% from a record high hit in mid-February, as Beijing stepped up regulatory pressure on the country's tech giants and platform companies.\n** China's securities regulator is setting up a team to review plans by Chinese companies for initial public offerings (IPOs) abroad.\n** On Wednesday, China's market regulator said it had fined a number of internet companies including Didi Chuxing , Tencent and Alibaba for failing to report earlier merger and acquisition deals for approval.\n** That came after China's cyberspace regulator said on Sunday that it had ordered smartphone app stores to stop offering Didi Global Inc's app after finding that the ride-hailing giant had illegally collected users' personal data.\n** Also weighing on sentiment were the latest headlines on Sino-U.S. tensions.\n** The Biden administration is set as early as Friday to add more than 10 Chinese companies to its economic blacklist over alleged human rights abuses and high-tech surveillance in Xinjiang, two sources told Reuters.\n** Late on Wednesday, the S&P Dow Jones Indices and FTSE Russell decided to remove more Chinese companies from their indices after an updated U.S. executive order barred domestic investment in firms with alleged ties to China's military.","news_type":1,"symbols_score_info":{"QNETCN":0.9,"HSI":0.9,"09988":0.9}},"isVote":1,"tweetType":1,"viewCount":2016,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":141974483,"gmtCreate":1625837295442,"gmtModify":1703749531105,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"Kkkk ","listText":"Kkkk ","text":"Kkkk","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141974483","repostId":"1113072261","repostType":4,"repost":{"id":"1113072261","kind":"news","pubTimestamp":1625823554,"share":"https://ttm.financial/m/news/1113072261?lang=en_US&edition=fundamental","pubTime":"2021-07-09 17:39","market":"us","language":"en","title":"GameStop Short Seller Melvin Capital Ended 2021 First-Half With 46% Loss: Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1113072261","media":"Benzinga","summary":"GameStop Corp. short seller Melvin Capital Management LP ended the first half of 2021 with a loss of","content":"<div>\n<p>GameStop Corp. short seller Melvin Capital Management LP ended the first half of 2021 with a loss of 46%, Bloomberg reported Thursday, citing people familiar with the matter.\nWhat Happened:Founded in ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/07/21909875/gamestop-short-seller-melvin-capital-ended-2021-first-half-with-46-loss-report\">Source Link</a>\n\n</div>\n","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GameStop Short Seller Melvin Capital Ended 2021 First-Half With 46% Loss: Report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGameStop Short Seller Melvin Capital Ended 2021 First-Half With 46% Loss: Report\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 17:39 GMT+8 <a href=https://www.benzinga.com/news/21/07/21909875/gamestop-short-seller-melvin-capital-ended-2021-first-half-with-46-loss-report><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GameStop Corp. short seller Melvin Capital Management LP ended the first half of 2021 with a loss of 46%, Bloomberg reported Thursday, citing people familiar with the matter.\nWhat Happened:Founded in ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/07/21909875/gamestop-short-seller-melvin-capital-ended-2021-first-half-with-46-loss-report\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站","AMC":"AMC院线"},"source_url":"https://www.benzinga.com/news/21/07/21909875/gamestop-short-seller-melvin-capital-ended-2021-first-half-with-46-loss-report","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113072261","content_text":"GameStop Corp. short seller Melvin Capital Management LP ended the first half of 2021 with a loss of 46%, Bloomberg reported Thursday, citing people familiar with the matter.\nWhat Happened:Founded in 2014 by Gabe Plotkin, a former portfolio manager for Steve Cohen, Melvin Capital was at the heart of the GameStop saga earlier this year.\nThe hedge fund, which managed $11 billion in assets as of June 1, is taking smaller-sized positions to limit exposure to single companies, as per the report.\nPlotkin has reportedly instructed his team of data scientists to watch social media and message boards to look for shares that are seeing high support from retail investors.\nWhy It Matters:Melvin Capital’s first-half results indicate the hedge fund is struggling to rebound from thelossesit incurred from betting against GameStop and other stonks - stocks popular with retail investors.\nMelvin Capital said in May it has closed out of all its public bearish positions in the first quarter. This included its listed put options in GameStop.\nIt was reported in June that London-based White Square Capital is shutting down after suffering huge losses during the retail trading frenzy earlier in the year. This marked one of the first hedge fund closures following the surge in shares of stonks.\nIn early June,AMC Entertainment Holdings Inc. and GameStop short-seller losses swelled up to$12 billionon a year-to-date basis. Both the stocks continue to seehigh interestfrom retail investors.\nPrice Action: AMC Entertainment shares closed almost 6.4% higher in Thursday’s regular trading session at $47.94, while GameStop shares closed almost 0.4% higher at $191.38.","news_type":1,"symbols_score_info":{"GME":0.9,"AMC":0.9}},"isVote":1,"tweetType":1,"viewCount":2246,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":141974061,"gmtCreate":1625837266653,"gmtModify":1703749529799,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141974061","repostId":"2150980376","repostType":4,"repost":{"id":"2150980376","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1625823947,"share":"https://ttm.financial/m/news/2150980376?lang=en_US&edition=fundamental","pubTime":"2021-07-09 17:45","market":"sh","language":"en","title":"China cuts reserve requirements to support economic recovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2150980376","media":"Reuters","summary":"BEIJING, July 9 (Reuters) - China's central bank said on Friday it would cut the amount of cash that","content":"<p>BEIJING, July 9 (Reuters) - China's central bank said on Friday it would cut the amount of cash that banks must hold as reserves, releasing around 1 trillion yuan ($154.19 billion) in long-term liquidity to help underpin an economic recovery that is starting to lose momentum.</p>\n<p>The People's Bank of China (PBOC) said on its website it would cut the reserve requirement ratio <a href=\"https://laohu8.com/S/RRR\">$(RRR)$</a> for all banks by 50 basis points (bps), effective on July 15.</p>\n<p>Banks that are subject to an RRR of 5% will be exempted from the new cut.</p>\n<p>The PBOC last cut the RRR in April last year, when the Chinese economy was still badly jolted by the coronavirus crisis. As the economy staged a strong rebound, aided by the surprisingly resilient exports, the PBOC had since shifted to a moderately tightening bias.</p>\n<p>The country's cabinet said on Wednesday that authorities will use timely cuts in RRR to help small firms cope with the negative impact from rising commodity prices, which came as a surprise to the market.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China cuts reserve requirements to support economic recovery</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina cuts reserve requirements to support economic recovery\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-09 17:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BEIJING, July 9 (Reuters) - China's central bank said on Friday it would cut the amount of cash that banks must hold as reserves, releasing around 1 trillion yuan ($154.19 billion) in long-term liquidity to help underpin an economic recovery that is starting to lose momentum.</p>\n<p>The People's Bank of China (PBOC) said on its website it would cut the reserve requirement ratio <a href=\"https://laohu8.com/S/RRR\">$(RRR)$</a> for all banks by 50 basis points (bps), effective on July 15.</p>\n<p>Banks that are subject to an RRR of 5% will be exempted from the new cut.</p>\n<p>The PBOC last cut the RRR in April last year, when the Chinese economy was still badly jolted by the coronavirus crisis. As the economy staged a strong rebound, aided by the surprisingly resilient exports, the PBOC had since shifted to a moderately tightening bias.</p>\n<p>The country's cabinet said on Wednesday that authorities will use timely cuts in RRR to help small firms cope with the negative impact from rising commodity prices, which came as a surprise to the market.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CAAS":"中汽系统","000001.SH":"上证指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2150980376","content_text":"BEIJING, July 9 (Reuters) - China's central bank said on Friday it would cut the amount of cash that banks must hold as reserves, releasing around 1 trillion yuan ($154.19 billion) in long-term liquidity to help underpin an economic recovery that is starting to lose momentum.\nThe People's Bank of China (PBOC) said on its website it would cut the reserve requirement ratio $(RRR)$ for all banks by 50 basis points (bps), effective on July 15.\nBanks that are subject to an RRR of 5% will be exempted from the new cut.\nThe PBOC last cut the RRR in April last year, when the Chinese economy was still badly jolted by the coronavirus crisis. As the economy staged a strong rebound, aided by the surprisingly resilient exports, the PBOC had since shifted to a moderately tightening bias.\nThe country's cabinet said on Wednesday that authorities will use timely cuts in RRR to help small firms cope with the negative impact from rising commodity prices, which came as a surprise to the market.","news_type":1,"symbols_score_info":{"000001.SH":0.9,"CAAS":0.9}},"isVote":1,"tweetType":1,"viewCount":1252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157137043,"gmtCreate":1625571578982,"gmtModify":1703743981828,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Fml ","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Fml ","text":"$Alibaba(BABA)$Fml","images":[{"img":"https://static.tigerbbs.com/c4795ba762ebdf7bb475df060911a49d","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/157137043","isVote":1,"tweetType":1,"viewCount":2199,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":156743989,"gmtCreate":1625238350241,"gmtModify":1703739237136,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Sobs ","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Sobs ","text":"$Alibaba(BABA)$Sobs","images":[{"img":"https://static.tigerbbs.com/b899ec0eacf287348884e35b865d69c7","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/156743989","isVote":1,"tweetType":1,"viewCount":1689,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":156710833,"gmtCreate":1625236509022,"gmtModify":1703739165398,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>Have been holding since Feb ","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>Have been holding since Feb ","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$Have been holding since Feb","images":[{"img":"https://static.tigerbbs.com/570612cd6514f7b5cb9efcf94dc5c7f5","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/156710833","isVote":1,"tweetType":1,"viewCount":1493,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":125241091,"gmtCreate":1624677099313,"gmtModify":1703843431131,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>LOLOL finally less than 10% ","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>LOLOL finally less than 10% ","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$LOLOL finally less than 10%","images":[{"img":"https://static.tigerbbs.com/6cf16fa79e2834e2fceb5d4dd2965904","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125241091","isVote":1,"tweetType":1,"viewCount":1392,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":125058705,"gmtCreate":1624637774207,"gmtModify":1703842566402,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"Wow ","listText":"Wow ","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125058705","repostId":"2146079086","repostType":4,"isVote":1,"tweetType":1,"viewCount":564,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103561043,"gmtCreate":1619793893482,"gmtModify":1704272507362,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":" Nice ","listText":" Nice ","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/103561043","repostId":"1180690637","repostType":4,"isVote":1,"tweetType":1,"viewCount":811,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103563501,"gmtCreate":1619793875303,"gmtModify":1704272506543,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"Nice ","listText":"Nice ","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/103563501","repostId":"1189807124","repostType":4,"repost":{"id":"1189807124","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1619791477,"share":"https://ttm.financial/m/news/1189807124?lang=en_US&edition=fundamental","pubTime":"2021-04-30 22:04","market":"us","language":"en","title":"Amazon once rose 2.4%, setting a record high in intraday trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1189807124","media":"Tiger Newspress","summary":"Amazon once rose 2.4%, setting a record high in intraday trading.Here’s what analysts are saying abo","content":"<p>Amazon once rose 2.4%, setting a record high in intraday trading.</p><p><img src=\"https://static.tigerbbs.com/9b9f7378d5970cada2dc37de1aa76935\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p>Here’s what analysts are saying about Amazon tripling profits</p><p>Swiss Bank UBS raises its price target as the COVID-19 pandemic caused boom in demand for home deliveries, helping Amazon triple profits</p><p>The COVID-19 pandemic has caused a boom in demand for home deliveries, which has helped AmazonAMZN,+1.75%triple its first-quarter profits.</p><p>The online retailer’s stock has risen 46% the past year and some analysts think it could still have further to go.</p><p>Michael Lasser, an analyst at Swiss bank UBSUBS,-0.92%,has lifted his price target for Amazon to $4,350 from $4,150, writing: “With broad-based strength across e-commerce & AWS, Amazon’s Q1 ’21 earnings report demonstrates why it remains the industry leader.”</p><p><b>Amazon’s pandemic profits top previous 3 years of earnings</b></p><p>Shyam Patil, an analyst from Susquehanna Financial Group, remains positive on Amazon.</p><p>“Business trends remain strong and should continue to do so throughout 2021,” he wrote. “Ultimately, we see AMZN as a long-term secular grower underpinned by its strong e-commerce, cloud, and advertising businesses.”</p><p><b>Should you buy Amazon stock? Analysts prefer it over other Big Tech companies</b></p><p>Trip Chowdhry, an analyst at Global Equities Research, noted the “solid results” and reiterated his view that Andy Jassy, who will replace founder Jeff Bezos as chief executive, will be a good boss.</p><p>Jassy currently runs Amazon Web Services, which Chowdhry says is benefiting from secular growth trends. “So many of you were panicked about CEO Transition,” he wrote. “Andy Jassy is a much better CEO than Jeff Bezos.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amazon once rose 2.4%, setting a record high in intraday trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon once rose 2.4%, setting a record high in intraday trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-04-30 22:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Amazon once rose 2.4%, setting a record high in intraday trading.</p><p><img src=\"https://static.tigerbbs.com/9b9f7378d5970cada2dc37de1aa76935\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p>Here’s what analysts are saying about Amazon tripling profits</p><p>Swiss Bank UBS raises its price target as the COVID-19 pandemic caused boom in demand for home deliveries, helping Amazon triple profits</p><p>The COVID-19 pandemic has caused a boom in demand for home deliveries, which has helped AmazonAMZN,+1.75%triple its first-quarter profits.</p><p>The online retailer’s stock has risen 46% the past year and some analysts think it could still have further to go.</p><p>Michael Lasser, an analyst at Swiss bank UBSUBS,-0.92%,has lifted his price target for Amazon to $4,350 from $4,150, writing: “With broad-based strength across e-commerce & AWS, Amazon’s Q1 ’21 earnings report demonstrates why it remains the industry leader.”</p><p><b>Amazon’s pandemic profits top previous 3 years of earnings</b></p><p>Shyam Patil, an analyst from Susquehanna Financial Group, remains positive on Amazon.</p><p>“Business trends remain strong and should continue to do so throughout 2021,” he wrote. “Ultimately, we see AMZN as a long-term secular grower underpinned by its strong e-commerce, cloud, and advertising businesses.”</p><p><b>Should you buy Amazon stock? Analysts prefer it over other Big Tech companies</b></p><p>Trip Chowdhry, an analyst at Global Equities Research, noted the “solid results” and reiterated his view that Andy Jassy, who will replace founder Jeff Bezos as chief executive, will be a good boss.</p><p>Jassy currently runs Amazon Web Services, which Chowdhry says is benefiting from secular growth trends. “So many of you were panicked about CEO Transition,” he wrote. “Andy Jassy is a much better CEO than Jeff Bezos.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189807124","content_text":"Amazon once rose 2.4%, setting a record high in intraday trading.Here’s what analysts are saying about Amazon tripling profitsSwiss Bank UBS raises its price target as the COVID-19 pandemic caused boom in demand for home deliveries, helping Amazon triple profitsThe COVID-19 pandemic has caused a boom in demand for home deliveries, which has helped AmazonAMZN,+1.75%triple its first-quarter profits.The online retailer’s stock has risen 46% the past year and some analysts think it could still have further to go.Michael Lasser, an analyst at Swiss bank UBSUBS,-0.92%,has lifted his price target for Amazon to $4,350 from $4,150, writing: “With broad-based strength across e-commerce & AWS, Amazon’s Q1 ’21 earnings report demonstrates why it remains the industry leader.”Amazon’s pandemic profits top previous 3 years of earningsShyam Patil, an analyst from Susquehanna Financial Group, remains positive on Amazon.“Business trends remain strong and should continue to do so throughout 2021,” he wrote. “Ultimately, we see AMZN as a long-term secular grower underpinned by its strong e-commerce, cloud, and advertising businesses.”Should you buy Amazon stock? Analysts prefer it over other Big Tech companiesTrip Chowdhry, an analyst at Global Equities Research, noted the “solid results” and reiterated his view that Andy Jassy, who will replace founder Jeff Bezos as chief executive, will be a good boss.Jassy currently runs Amazon Web Services, which Chowdhry says is benefiting from secular growth trends. “So many of you were panicked about CEO Transition,” he wrote. “Andy Jassy is a much better CEO than Jeff Bezos.”","news_type":1,"symbols_score_info":{"AMZN":0.9}},"isVote":1,"tweetType":1,"viewCount":536,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103560526,"gmtCreate":1619793781265,"gmtModify":1704272503413,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"Nice ","listText":"Nice ","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/103560526","repostId":"1129215602","repostType":4,"repost":{"id":"1129215602","kind":"news","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1619787703,"share":"https://ttm.financial/m/news/1129215602?lang=en_US&edition=fundamental","pubTime":"2021-04-30 21:01","market":"us","language":"en","title":"Joe Biden's $6 trillion ambition","url":"https://stock-news.laohu8.com/highlight/detail?id=1129215602","media":"Reuters","summary":"In his first 100 days in office, President Joe Biden has offered up roughly $6 trillion in spending ","content":"<p>In his first 100 days in office, President Joe Biden has offered up roughly $6 trillion in spending proposals and so far has delivered on roughly a third of it.</p><p>His plans cover a range of policy goals: Lifting the economy out of the COVID-19 recession; restoring blue collar jobs; beefing up critical U.S. infrastructure; levying higher taxes on corporations and the wealthiest Americans; securing affordable child care for American families.</p><p>The first-term Democrat’s vision to reshape the U.S. economy has come in the form of three broad fiscal programs, each bearing a three-letter acronym distinguished from one another only by their middle initials: The ARP (American Rescue Plan); the AJP (American Jobs Plan); and AFP (American Families Plan).</p><p>Here’s where they stand:</p><p>ARP: American Rescue Plan - $1.9 trillion</p><p>Status: Passed</p><p>The first of Biden’s proposals, floated before he was sworn into office on Jan. 20, is the only of the three so far to have been enacted into law. It passed in March on party-line votes, backed by Democrats, rejected by Republicans.</p><p>Its signature components were $1,400 one-time payments that went out to most American households this spring and the extension of a $300 a week federal enhancement to state unemployment benefits until September. Those funds helped lift consumer spending in the first quarter at an annualized rate of 10.7%, among the largest gains in the post-World War Two era.</p><p>The ARP also included funds to accelerate the COVID-19 vaccination campaign and to assist the businesses and communities most affected by the pandemic. The United States has emerged as one of the world leaders in the COVID-19 inoculation effort, with 43% of U.S. adults having gotten at least one dose of vaccine and 30% now fully vaccinated.</p><p>AJP: American Jobs Plan - $2.3 trillion</p><p>Status: Blueprint</p><p>Biden announced what he bills as his “blue collar blueprint” at the end of March, and while it has been the focus of much discussion in Washington, no formal proposal has yet surfaced on Capitol Hill.</p><p>The plan’s two biggest buckets - at $650 billion each - would:</p><p>* Fund traditional public transportation projects like roads and bridges while underwriting investments in the infrastructure to kick the transition to electric vehicles into high gear; and</p><p>* Pay to refurbish aging public schools and decaying public water systems and expand broadband access for the 35% of rural Americans lacking such high-speed communications connectivity.</p><p>Other components of the AJP would provide funds for home- or community-based care for the elderly and disabled and would invest in domestic manufacturing for industries the Biden administration considers critical to the national interest, such as semiconductors and green energy.</p><p>To pay for these, Biden has proposed raising the corporate tax rate to 28% from 21%; eliminating all fossil fuel industry subsidies and loopholes; and establishing a minimum tax on income companies use to report profits to investors.</p><p>AFP: American Families Plan - $1.8 trillion</p><p>Status: Blueprint</p><p>The last of Biden’s proposals is a mix of new spending, totaling $1 trillion, and tax credits for working families, about $800 billion. It went up the flagpole in late April and features his first stab at getting the wealthiest Americans to pay more in taxes. Like the AJP, it has yet to get as far as a formal bill before Congress.</p><p>Its key spending elements include provisions:</p><p>* Aiming to help working parents cover childcare expenses and subsidizing daycare costs for families with kids under 5 and provide free preschool for 3- and 4-year-olds.</p><p>* Providing free community college tuition; boosting a federal tuition grant program; and subsidizing tuition for students from middle-class families attending an historically Black college or university, or HBCU.</p><p>* Extending the child tax credit, included in the ARP enacted in March, through 2025. The current credit, essentially another monthly payment from the government for most families, will sunset at the end of this year.</p><p>* Roughly doubling the tax rate paid by high earners on their investment income to 39.6% from 20% now and lifting the highest tax rate on ordinary income to 39.6% from 37%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Joe Biden's $6 trillion ambition</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJoe Biden's $6 trillion ambition\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-04-30 21:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>In his first 100 days in office, President Joe Biden has offered up roughly $6 trillion in spending proposals and so far has delivered on roughly a third of it.</p><p>His plans cover a range of policy goals: Lifting the economy out of the COVID-19 recession; restoring blue collar jobs; beefing up critical U.S. infrastructure; levying higher taxes on corporations and the wealthiest Americans; securing affordable child care for American families.</p><p>The first-term Democrat’s vision to reshape the U.S. economy has come in the form of three broad fiscal programs, each bearing a three-letter acronym distinguished from one another only by their middle initials: The ARP (American Rescue Plan); the AJP (American Jobs Plan); and AFP (American Families Plan).</p><p>Here’s where they stand:</p><p>ARP: American Rescue Plan - $1.9 trillion</p><p>Status: Passed</p><p>The first of Biden’s proposals, floated before he was sworn into office on Jan. 20, is the only of the three so far to have been enacted into law. It passed in March on party-line votes, backed by Democrats, rejected by Republicans.</p><p>Its signature components were $1,400 one-time payments that went out to most American households this spring and the extension of a $300 a week federal enhancement to state unemployment benefits until September. Those funds helped lift consumer spending in the first quarter at an annualized rate of 10.7%, among the largest gains in the post-World War Two era.</p><p>The ARP also included funds to accelerate the COVID-19 vaccination campaign and to assist the businesses and communities most affected by the pandemic. The United States has emerged as one of the world leaders in the COVID-19 inoculation effort, with 43% of U.S. adults having gotten at least one dose of vaccine and 30% now fully vaccinated.</p><p>AJP: American Jobs Plan - $2.3 trillion</p><p>Status: Blueprint</p><p>Biden announced what he bills as his “blue collar blueprint” at the end of March, and while it has been the focus of much discussion in Washington, no formal proposal has yet surfaced on Capitol Hill.</p><p>The plan’s two biggest buckets - at $650 billion each - would:</p><p>* Fund traditional public transportation projects like roads and bridges while underwriting investments in the infrastructure to kick the transition to electric vehicles into high gear; and</p><p>* Pay to refurbish aging public schools and decaying public water systems and expand broadband access for the 35% of rural Americans lacking such high-speed communications connectivity.</p><p>Other components of the AJP would provide funds for home- or community-based care for the elderly and disabled and would invest in domestic manufacturing for industries the Biden administration considers critical to the national interest, such as semiconductors and green energy.</p><p>To pay for these, Biden has proposed raising the corporate tax rate to 28% from 21%; eliminating all fossil fuel industry subsidies and loopholes; and establishing a minimum tax on income companies use to report profits to investors.</p><p>AFP: American Families Plan - $1.8 trillion</p><p>Status: Blueprint</p><p>The last of Biden’s proposals is a mix of new spending, totaling $1 trillion, and tax credits for working families, about $800 billion. It went up the flagpole in late April and features his first stab at getting the wealthiest Americans to pay more in taxes. Like the AJP, it has yet to get as far as a formal bill before Congress.</p><p>Its key spending elements include provisions:</p><p>* Aiming to help working parents cover childcare expenses and subsidizing daycare costs for families with kids under 5 and provide free preschool for 3- and 4-year-olds.</p><p>* Providing free community college tuition; boosting a federal tuition grant program; and subsidizing tuition for students from middle-class families attending an historically Black college or university, or HBCU.</p><p>* Extending the child tax credit, included in the ARP enacted in March, through 2025. The current credit, essentially another monthly payment from the government for most families, will sunset at the end of this year.</p><p>* Roughly doubling the tax rate paid by high earners on their investment income to 39.6% from 20% now and lifting the highest tax rate on ordinary income to 39.6% from 37%.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129215602","content_text":"In his first 100 days in office, President Joe Biden has offered up roughly $6 trillion in spending proposals and so far has delivered on roughly a third of it.His plans cover a range of policy goals: Lifting the economy out of the COVID-19 recession; restoring blue collar jobs; beefing up critical U.S. infrastructure; levying higher taxes on corporations and the wealthiest Americans; securing affordable child care for American families.The first-term Democrat’s vision to reshape the U.S. economy has come in the form of three broad fiscal programs, each bearing a three-letter acronym distinguished from one another only by their middle initials: The ARP (American Rescue Plan); the AJP (American Jobs Plan); and AFP (American Families Plan).Here’s where they stand:ARP: American Rescue Plan - $1.9 trillionStatus: PassedThe first of Biden’s proposals, floated before he was sworn into office on Jan. 20, is the only of the three so far to have been enacted into law. It passed in March on party-line votes, backed by Democrats, rejected by Republicans.Its signature components were $1,400 one-time payments that went out to most American households this spring and the extension of a $300 a week federal enhancement to state unemployment benefits until September. Those funds helped lift consumer spending in the first quarter at an annualized rate of 10.7%, among the largest gains in the post-World War Two era.The ARP also included funds to accelerate the COVID-19 vaccination campaign and to assist the businesses and communities most affected by the pandemic. The United States has emerged as one of the world leaders in the COVID-19 inoculation effort, with 43% of U.S. adults having gotten at least one dose of vaccine and 30% now fully vaccinated.AJP: American Jobs Plan - $2.3 trillionStatus: BlueprintBiden announced what he bills as his “blue collar blueprint” at the end of March, and while it has been the focus of much discussion in Washington, no formal proposal has yet surfaced on Capitol Hill.The plan’s two biggest buckets - at $650 billion each - would:* Fund traditional public transportation projects like roads and bridges while underwriting investments in the infrastructure to kick the transition to electric vehicles into high gear; and* Pay to refurbish aging public schools and decaying public water systems and expand broadband access for the 35% of rural Americans lacking such high-speed communications connectivity.Other components of the AJP would provide funds for home- or community-based care for the elderly and disabled and would invest in domestic manufacturing for industries the Biden administration considers critical to the national interest, such as semiconductors and green energy.To pay for these, Biden has proposed raising the corporate tax rate to 28% from 21%; eliminating all fossil fuel industry subsidies and loopholes; and establishing a minimum tax on income companies use to report profits to investors.AFP: American Families Plan - $1.8 trillionStatus: BlueprintThe last of Biden’s proposals is a mix of new spending, totaling $1 trillion, and tax credits for working families, about $800 billion. It went up the flagpole in late April and features his first stab at getting the wealthiest Americans to pay more in taxes. Like the AJP, it has yet to get as far as a formal bill before Congress.Its key spending elements include provisions:* Aiming to help working parents cover childcare expenses and subsidizing daycare costs for families with kids under 5 and provide free preschool for 3- and 4-year-olds.* Providing free community college tuition; boosting a federal tuition grant program; and subsidizing tuition for students from middle-class families attending an historically Black college or university, or HBCU.* Extending the child tax credit, included in the ARP enacted in March, through 2025. The current credit, essentially another monthly payment from the government for most families, will sunset at the end of this year.* Roughly doubling the tax rate paid by high earners on their investment income to 39.6% from 20% now and lifting the highest tax rate on ordinary income to 39.6% from 37%.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":663,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103587581,"gmtCreate":1619793707443,"gmtModify":1704272502269,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"Nice ","listText":"Nice ","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/103587581","repostId":"1165708828","repostType":4,"repost":{"id":"1165708828","kind":"news","pubTimestamp":1619792862,"share":"https://ttm.financial/m/news/1165708828?lang=en_US&edition=fundamental","pubTime":"2021-04-30 22:27","market":"us","language":"en","title":"3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1165708828","media":"Motley Fool","summary":"For more than a year, patient investors have been handsomely rewarded. All three of the market's maj","content":"<p>For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, 2020.</p>\n<p>Yet, not all stocks have participated in the rally. Over the trailing year (through April 27, 2021), around 110 stocks with at least a $300 million market cap have declined by 20% (or more). Given the aforementioned big gains in the<b>S&P 500</b>,<b>Dow Jones Industrial Average</b>, and<b>Nasdaq Composite</b>, this represents a huge underperformance.</p>\n<p>But according to analysts on Wall Street, some of these underperformers have a good chance to bounce back in a big way over the coming year. Based on consensus one-year price targets, the following three turnaround stocks offer upside ranging from 91% to as much as 104%.</p>\n<p>Sarepta Therapeutics: Implied upside of 91%</p>\n<p>Many of the worst-performing equities over the past year arebiotech stocks. With investors rolling the dice on future clinical outcomes, trial data announcements can yield wild price swings for drug developers. Shareholders of specialized drug developer<b>Sarepta Therapeutics</b>(NASDAQ:SRPT)learned this in January when shares of the company were halved in a day. But if Wall Street's one-year price target is correct, Sarepta could recoup most of its losses by gaining 91% from its April 27 close.</p>\n<p>Sarepta's bread and butter is its research in treating Duchenne Muscular Dystrophy (DMD). DMD is an incurable disease diagnosed in children that leads to the destruction of muscle and causes premature death. To date, the company has had the U.S. Food and Drug Administration (FDA) approve three of its gene-specific DMD treatments, which are designed to increase the production of dystrophin.</p>\n<p>However, themake-or-break treatmentin the company's pipeline is SRP-9001. This is an experimental treatment that utilizes an adeno-associated virus to deliver a gene to muscle tissue that \"programs\" for micro-dystrophin production. In other words, SRP-9001 would allow the company to treat a much larger percentage of DMD patients.</p>\n<p>The Part 1 data release of Study 102 evaluating SRP-9001 in DMD patients aged 4 to 7 is why the stock was halved in January. Although treated participants showed an increase in their North Star Ambulatory Assessment (NSAA) total score,it wasn't statistically significant. Sarepta, however, blamed this disappointment on fitness differences in its patients during the study and expects a much different outcome in the latter half of this study. Part 2 of Study 102 is, therefore, Sarepta's make-or-break DMD moment.</p>\n<p>Intercept Pharmaceuticals: Implied upside of 97%</p>\n<p>If you wanteven more upside potential, Wall Street would steer you toward small-cap<b>Intercept Pharmaceuticals</b>(NASDAQ:ICPT). Among the 4,000-plus securities with at least a $300 million market cap, it holds the distinction of being the absolute worst performer over the trailing year (down 75%). The only solace is that Wall Street's consensus price target would see Intercept gain 97% over the coming year.</p>\n<p>Similar to Sarepta, Intercept's future predominantly lies with one indication: nonalcoholic steatohepatitis, or NASH. NASH is a liver disease that affects between 2% and 5% of the U.S. adult population and has no FDA-approved cure. It can lead to fibrosis, liver cancer, and even death. It's been estimated that NASH represents a $35 billion treatment opportunity.</p>\n<p>Intercept is at the forefront of that opportunity, but it's not been without its hiccups. Experimental treatment obeticholic acid (OCA)met one of its two co-primary endpointsin the phase 3 Regenerate study -- a statistically significant reduction in liver fibrosis without a worsening in NASH. Only one met endpoint was needed to declare the trial a success.</p>\n<p>On the other hand, the highest dose (also the most effective) led to considerably higher instances of pruritus (itching) and trial discontinuation, relative to the placebo. Perhaps unsurprisingly, Interceptreceived a Complete Response Letterfrom the FDA following its new drug application to supply additional safety data.</p>\n<p>If OCA were to be approved, even for a small subset of the sickest patients, it would represent a greater than $1 billion sales opportunity.</p>\n<p>It's also worth noting that OCA is already approved under the brand name Ocaliva as a treatment for primary biliary cholangitis (PBC). With Ocaliva's PBC sales expected to hit at least $325 million in 2021 (nearly half the company's market cap), investors look to begetting a shot at NASH success nearly for free.</p>\n<p>Inovio Pharmaceuticals: Implied upside of 104%</p>\n<p>Yet another biotech stock withbig-time upside potential, according to Wall Street, is<b>Inovio Pharmaceuticals</b>(NASDAQ:INO). Shares of the company have been clobbered recently, but are expected to rally by 104% to nearly $15 based on the consensus 12-month price target of analysts.</p>\n<p>For much of the past year, the promise and peril of Inovio have rested with its development of a coronavirus disease 2019 (COVID-19) vaccine. The company's candidate, INO-4800, achieved immunological responses in 38 of 38 patients in phase 1 studies and looked to be on track to be among the roughly six or so early contenders to bring a COVID-19 vaccine to market in the United States.</p>\n<p>Unfortunately, Inovio's phase 2 and 3 studies hit a snag. The FDA placed a partial clinical hold on both phases and requested additional information concerning INO-4800 and the company's Cellectra delivery device. Cellectra uses electrical impulses to open pores in cells to allow plasmids to enter. Though the partial hold on the phase 2 study was lifted, the company has yet to run an all-important phase 3 study and may choose to do so outside the United States. To top things off, the U.S. Department of Defense notified Inovio that it wouldno longer be providing funding for its phase 3 study.</p>\n<p>There are two very big problems here. First, Inovio is running out of time to become a major player in treating COVID-19. The U.S. vaccination campaign will likely be complete sometime in July, and major players like<b>Johnson & Johnson</b> can produce up to 3 billion doses for the global market this year. As a reminder, J&J's vaccine is a single-dose treatment.</p>\n<p>The other potential red flag isInovio's track record. The company may have an intriguing delivery device in Cellectra, as well as nearly a dozen unique compounds in clinical trials, but it's yet to have the FDA approve any of its experimental treatments in four decades.</p>\n<p>With a number of its studies partnered, it's always possible Inovio could turn itself around. But given its track record, it may be best off avoided.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-30 22:27 GMT+8 <a href=https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165708828","content_text":"For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, 2020.\nYet, not all stocks have participated in the rally. Over the trailing year (through April 27, 2021), around 110 stocks with at least a $300 million market cap have declined by 20% (or more). Given the aforementioned big gains in theS&P 500,Dow Jones Industrial Average, andNasdaq Composite, this represents a huge underperformance.\nBut according to analysts on Wall Street, some of these underperformers have a good chance to bounce back in a big way over the coming year. Based on consensus one-year price targets, the following three turnaround stocks offer upside ranging from 91% to as much as 104%.\nSarepta Therapeutics: Implied upside of 91%\nMany of the worst-performing equities over the past year arebiotech stocks. With investors rolling the dice on future clinical outcomes, trial data announcements can yield wild price swings for drug developers. Shareholders of specialized drug developerSarepta Therapeutics(NASDAQ:SRPT)learned this in January when shares of the company were halved in a day. But if Wall Street's one-year price target is correct, Sarepta could recoup most of its losses by gaining 91% from its April 27 close.\nSarepta's bread and butter is its research in treating Duchenne Muscular Dystrophy (DMD). DMD is an incurable disease diagnosed in children that leads to the destruction of muscle and causes premature death. To date, the company has had the U.S. Food and Drug Administration (FDA) approve three of its gene-specific DMD treatments, which are designed to increase the production of dystrophin.\nHowever, themake-or-break treatmentin the company's pipeline is SRP-9001. This is an experimental treatment that utilizes an adeno-associated virus to deliver a gene to muscle tissue that \"programs\" for micro-dystrophin production. In other words, SRP-9001 would allow the company to treat a much larger percentage of DMD patients.\nThe Part 1 data release of Study 102 evaluating SRP-9001 in DMD patients aged 4 to 7 is why the stock was halved in January. Although treated participants showed an increase in their North Star Ambulatory Assessment (NSAA) total score,it wasn't statistically significant. Sarepta, however, blamed this disappointment on fitness differences in its patients during the study and expects a much different outcome in the latter half of this study. Part 2 of Study 102 is, therefore, Sarepta's make-or-break DMD moment.\nIntercept Pharmaceuticals: Implied upside of 97%\nIf you wanteven more upside potential, Wall Street would steer you toward small-capIntercept Pharmaceuticals(NASDAQ:ICPT). Among the 4,000-plus securities with at least a $300 million market cap, it holds the distinction of being the absolute worst performer over the trailing year (down 75%). The only solace is that Wall Street's consensus price target would see Intercept gain 97% over the coming year.\nSimilar to Sarepta, Intercept's future predominantly lies with one indication: nonalcoholic steatohepatitis, or NASH. NASH is a liver disease that affects between 2% and 5% of the U.S. adult population and has no FDA-approved cure. It can lead to fibrosis, liver cancer, and even death. It's been estimated that NASH represents a $35 billion treatment opportunity.\nIntercept is at the forefront of that opportunity, but it's not been without its hiccups. Experimental treatment obeticholic acid (OCA)met one of its two co-primary endpointsin the phase 3 Regenerate study -- a statistically significant reduction in liver fibrosis without a worsening in NASH. Only one met endpoint was needed to declare the trial a success.\nOn the other hand, the highest dose (also the most effective) led to considerably higher instances of pruritus (itching) and trial discontinuation, relative to the placebo. Perhaps unsurprisingly, Interceptreceived a Complete Response Letterfrom the FDA following its new drug application to supply additional safety data.\nIf OCA were to be approved, even for a small subset of the sickest patients, it would represent a greater than $1 billion sales opportunity.\nIt's also worth noting that OCA is already approved under the brand name Ocaliva as a treatment for primary biliary cholangitis (PBC). With Ocaliva's PBC sales expected to hit at least $325 million in 2021 (nearly half the company's market cap), investors look to begetting a shot at NASH success nearly for free.\nInovio Pharmaceuticals: Implied upside of 104%\nYet another biotech stock withbig-time upside potential, according to Wall Street, isInovio Pharmaceuticals(NASDAQ:INO). Shares of the company have been clobbered recently, but are expected to rally by 104% to nearly $15 based on the consensus 12-month price target of analysts.\nFor much of the past year, the promise and peril of Inovio have rested with its development of a coronavirus disease 2019 (COVID-19) vaccine. The company's candidate, INO-4800, achieved immunological responses in 38 of 38 patients in phase 1 studies and looked to be on track to be among the roughly six or so early contenders to bring a COVID-19 vaccine to market in the United States.\nUnfortunately, Inovio's phase 2 and 3 studies hit a snag. The FDA placed a partial clinical hold on both phases and requested additional information concerning INO-4800 and the company's Cellectra delivery device. Cellectra uses electrical impulses to open pores in cells to allow plasmids to enter. Though the partial hold on the phase 2 study was lifted, the company has yet to run an all-important phase 3 study and may choose to do so outside the United States. To top things off, the U.S. Department of Defense notified Inovio that it wouldno longer be providing funding for its phase 3 study.\nThere are two very big problems here. First, Inovio is running out of time to become a major player in treating COVID-19. The U.S. vaccination campaign will likely be complete sometime in July, and major players likeJohnson & Johnson can produce up to 3 billion doses for the global market this year. As a reminder, J&J's vaccine is a single-dose treatment.\nThe other potential red flag isInovio's track record. The company may have an intriguing delivery device in Cellectra, as well as nearly a dozen unique compounds in clinical trials, but it's yet to have the FDA approve any of its experimental treatments in four decades.\nWith a number of its studies partnered, it's always possible Inovio could turn itself around. But given its track record, it may be best off avoided.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":579,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103587837,"gmtCreate":1619793694329,"gmtModify":1704272501779,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"Nice ","listText":"Nice ","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/103587837","repostId":"1142070002","repostType":4,"repost":{"id":"1142070002","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1619792975,"share":"https://ttm.financial/m/news/1142070002?lang=en_US&edition=fundamental","pubTime":"2021-04-30 22:29","market":"us","language":"en","title":"NIO rose more than 5%, after falling nearly 4% before","url":"https://stock-news.laohu8.com/highlight/detail?id=1142070002","media":"Tiger Newspress","summary":"NIO Earnings Looked a Lot Like Ford’s. What to Know.Chinese electric vehicle maker NIO posted better than expected first quarter results. But the global automotive microchip shortage will hit production in the coming months.NIO is a highly valued, high-growth stock. Now NIO bulls have to decide whether solid earnings will trump the growth hiccup or whether the chip shortage can hurt the company in the long run.NIO lost 23 cents a share on an adjusted, non-GAAP basis, from $1.2 billion in sales.","content":"<p>NIO rose more than 5%, after falling nearly 4% before.</p><p><img src=\"https://static.tigerbbs.com/80881ae9e6de48ac5e3733583db3ba9e\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p><b>NIO Earnings Looked a Lot Like Ford’s. What to Know.</b></p><p>Chinese electric vehicle maker NIO posted better than expected first quarter results. But the global automotive microchip shortage will hit production in the coming months.</p><p>NIO (ticker: NIO) is a highly valued, high-growth stock. Now NIO bulls have to decide whether solid earnings will trump the growth hiccup or whether the chip shortage can hurt the company in the long run.</p><p>NIO lost 23 cents a share on an adjusted, non-GAAP basis, from $1.2 billion in sales. Wall Street was looking for a comparable 84 cent loss from $1.1 billion in sales. NIO’s corporate gross profit margin came in at 19.5%, about 3 percentage points better than analysts projected and up from negative 12% a year ago. First quarter results look solid.</p><p>The stock isn’t moving though. NIO reported numbers at 5:30 p.m. eastern time and not a lot of stock is trading after hours. NIO shares closed down 5.3% in Thursday trading. TheS&P 500 and Dow Jones Industrial Average rose about 0.7%.</p><p>“NIO started the year of 2021 with a new quarterly delivery record of 20,060 vehicles in the first quarter,” said CEO William Bin Li in the company’s news release. “The overall demand for our products continues to be quite strong, but the supply chain is still facing significant challenges due to the semiconductor shortage.”</p><p>Management called the chip situation “very severe” on its conference call and projected 21,000 to 22,000 vehicle deliveries for the second quarter and sales of about $1.3 billion. The Street is projecting $1.2 billion in sales. But the unit delivery guidance is a little lower than Deutsche Bank analyst Edison Yu had expected.</p><p>For the full year, Yu is modeling 95,000 deliveries. With about 42,000 deliveries likely for the first half of 2021, the resolution of the global chip shortage will go a long way to deciding whether or not NIO can reach Yu’s number.</p><p>Yu rates NIO shares Buy and has a $60 price target for the stock.</p><p>The overall quarter feels a little like Ford Motor‘s (F) quarter, which was reported Wednesday. Ford reported sales and earnings far better than Wall Street projected. Unit volumes were below the company’s internal projections, but improving vehicle mix boosted sales beyond Street projections. Ford prioritized making higher-end vehicles in the face of limited chip supply. Looking ahead, Ford said the impact of the chip shortage would be at the high end of the company’s initial $1 billion to $2.5 billion cost guidance.</p><p>Ford stock close down 9.4% Thursday, the day after the Wednesday evening report. The NIO second-quarter guidance isn’t as surprising as Ford’s. And NIO doesn’t have full-year guidance. But calling NIO’s stock price reaction is difficult.</p><p>Ford trades for less than 7 times estimated 2022 earnings. NIO is expected to become profitable on a full-year basis in 2022. What’s more, NIO is worth about 50% more than Ford.</p><p>NIO’s conference call wrapped up about 10 p.m. eastern time. After the chip shortage, analysts focused questions on EV competition in China and NIO’s production expansion. NIO is putting in place capacity to produce hundreds of thousands of vehicles in coming years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NIO rose more than 5%, after falling nearly 4% before</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNIO rose more than 5%, after falling nearly 4% before\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-04-30 22:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NIO rose more than 5%, after falling nearly 4% before.</p><p><img src=\"https://static.tigerbbs.com/80881ae9e6de48ac5e3733583db3ba9e\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p><b>NIO Earnings Looked a Lot Like Ford’s. What to Know.</b></p><p>Chinese electric vehicle maker NIO posted better than expected first quarter results. But the global automotive microchip shortage will hit production in the coming months.</p><p>NIO (ticker: NIO) is a highly valued, high-growth stock. Now NIO bulls have to decide whether solid earnings will trump the growth hiccup or whether the chip shortage can hurt the company in the long run.</p><p>NIO lost 23 cents a share on an adjusted, non-GAAP basis, from $1.2 billion in sales. Wall Street was looking for a comparable 84 cent loss from $1.1 billion in sales. NIO’s corporate gross profit margin came in at 19.5%, about 3 percentage points better than analysts projected and up from negative 12% a year ago. First quarter results look solid.</p><p>The stock isn’t moving though. NIO reported numbers at 5:30 p.m. eastern time and not a lot of stock is trading after hours. NIO shares closed down 5.3% in Thursday trading. TheS&P 500 and Dow Jones Industrial Average rose about 0.7%.</p><p>“NIO started the year of 2021 with a new quarterly delivery record of 20,060 vehicles in the first quarter,” said CEO William Bin Li in the company’s news release. “The overall demand for our products continues to be quite strong, but the supply chain is still facing significant challenges due to the semiconductor shortage.”</p><p>Management called the chip situation “very severe” on its conference call and projected 21,000 to 22,000 vehicle deliveries for the second quarter and sales of about $1.3 billion. The Street is projecting $1.2 billion in sales. But the unit delivery guidance is a little lower than Deutsche Bank analyst Edison Yu had expected.</p><p>For the full year, Yu is modeling 95,000 deliveries. With about 42,000 deliveries likely for the first half of 2021, the resolution of the global chip shortage will go a long way to deciding whether or not NIO can reach Yu’s number.</p><p>Yu rates NIO shares Buy and has a $60 price target for the stock.</p><p>The overall quarter feels a little like Ford Motor‘s (F) quarter, which was reported Wednesday. Ford reported sales and earnings far better than Wall Street projected. Unit volumes were below the company’s internal projections, but improving vehicle mix boosted sales beyond Street projections. Ford prioritized making higher-end vehicles in the face of limited chip supply. Looking ahead, Ford said the impact of the chip shortage would be at the high end of the company’s initial $1 billion to $2.5 billion cost guidance.</p><p>Ford stock close down 9.4% Thursday, the day after the Wednesday evening report. The NIO second-quarter guidance isn’t as surprising as Ford’s. And NIO doesn’t have full-year guidance. But calling NIO’s stock price reaction is difficult.</p><p>Ford trades for less than 7 times estimated 2022 earnings. NIO is expected to become profitable on a full-year basis in 2022. What’s more, NIO is worth about 50% more than Ford.</p><p>NIO’s conference call wrapped up about 10 p.m. eastern time. After the chip shortage, analysts focused questions on EV competition in China and NIO’s production expansion. NIO is putting in place capacity to produce hundreds of thousands of vehicles in coming years.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142070002","content_text":"NIO rose more than 5%, after falling nearly 4% before.NIO Earnings Looked a Lot Like Ford’s. What to Know.Chinese electric vehicle maker NIO posted better than expected first quarter results. But the global automotive microchip shortage will hit production in the coming months.NIO (ticker: NIO) is a highly valued, high-growth stock. Now NIO bulls have to decide whether solid earnings will trump the growth hiccup or whether the chip shortage can hurt the company in the long run.NIO lost 23 cents a share on an adjusted, non-GAAP basis, from $1.2 billion in sales. Wall Street was looking for a comparable 84 cent loss from $1.1 billion in sales. NIO’s corporate gross profit margin came in at 19.5%, about 3 percentage points better than analysts projected and up from negative 12% a year ago. First quarter results look solid.The stock isn’t moving though. NIO reported numbers at 5:30 p.m. eastern time and not a lot of stock is trading after hours. NIO shares closed down 5.3% in Thursday trading. TheS&P 500 and Dow Jones Industrial Average rose about 0.7%.“NIO started the year of 2021 with a new quarterly delivery record of 20,060 vehicles in the first quarter,” said CEO William Bin Li in the company’s news release. “The overall demand for our products continues to be quite strong, but the supply chain is still facing significant challenges due to the semiconductor shortage.”Management called the chip situation “very severe” on its conference call and projected 21,000 to 22,000 vehicle deliveries for the second quarter and sales of about $1.3 billion. The Street is projecting $1.2 billion in sales. But the unit delivery guidance is a little lower than Deutsche Bank analyst Edison Yu had expected.For the full year, Yu is modeling 95,000 deliveries. With about 42,000 deliveries likely for the first half of 2021, the resolution of the global chip shortage will go a long way to deciding whether or not NIO can reach Yu’s number.Yu rates NIO shares Buy and has a $60 price target for the stock.The overall quarter feels a little like Ford Motor‘s (F) quarter, which was reported Wednesday. Ford reported sales and earnings far better than Wall Street projected. Unit volumes were below the company’s internal projections, but improving vehicle mix boosted sales beyond Street projections. Ford prioritized making higher-end vehicles in the face of limited chip supply. Looking ahead, Ford said the impact of the chip shortage would be at the high end of the company’s initial $1 billion to $2.5 billion cost guidance.Ford stock close down 9.4% Thursday, the day after the Wednesday evening report. The NIO second-quarter guidance isn’t as surprising as Ford’s. And NIO doesn’t have full-year guidance. But calling NIO’s stock price reaction is difficult.Ford trades for less than 7 times estimated 2022 earnings. NIO is expected to become profitable on a full-year basis in 2022. What’s more, NIO is worth about 50% more than Ford.NIO’s conference call wrapped up about 10 p.m. eastern time. After the chip shortage, analysts focused questions on EV competition in China and NIO’s production expansion. NIO is putting in place capacity to produce hundreds of thousands of vehicles in coming years.","news_type":1,"symbols_score_info":{"NIO":0.9}},"isVote":1,"tweetType":1,"viewCount":774,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109549025,"gmtCreate":1619706741967,"gmtModify":1704271152015,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>wth is wrong w this ","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>wth is wrong w this ","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$wth is wrong w this","images":[{"img":"https://static.tigerbbs.com/346d4f7efb93d43c0da3a3de3ea167db","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/109549025","isVote":1,"tweetType":1,"viewCount":788,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":100592549,"gmtCreate":1619620128681,"gmtModify":1704726958253,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>-.- ","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>-.- ","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$-.-","images":[{"img":"https://static.tigerbbs.com/168921d010834c409f7de17324f9eeb8","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/100592549","isVote":1,"tweetType":1,"viewCount":834,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":372203021,"gmtCreate":1619216686263,"gmtModify":1704721313245,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>I am worried ","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>I am worried ","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$I am worried","images":[{"img":"https://static.tigerbbs.com/b54bb47eae9c3d1f5bb2607d4a7cfa3e","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/372203021","isVote":1,"tweetType":1,"viewCount":701,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":372200520,"gmtCreate":1619216534160,"gmtModify":1704721310790,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKK\">$ARK Innovation ETF(ARKK)$</a>Waiting for it to recover ","listText":"<a href=\"https://laohu8.com/S/ARKK\">$ARK Innovation ETF(ARKK)$</a>Waiting for it to recover ","text":"$ARK Innovation ETF(ARKK)$Waiting for it to recover","images":[{"img":"https://static.tigerbbs.com/3ebf96a80ddb9fc2608eda7e9369a1a2","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/372200520","isVote":1,"tweetType":1,"viewCount":1059,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":103561043,"gmtCreate":1619793893482,"gmtModify":1704272507362,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":" Nice ","listText":" Nice ","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/103561043","repostId":"1180690637","repostType":4,"isVote":1,"tweetType":1,"viewCount":811,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":372203021,"gmtCreate":1619216686263,"gmtModify":1704721313245,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>I am worried ","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>I am worried ","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$I am worried","images":[{"img":"https://static.tigerbbs.com/b54bb47eae9c3d1f5bb2607d4a7cfa3e","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/372203021","isVote":1,"tweetType":1,"viewCount":701,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":156710833,"gmtCreate":1625236509022,"gmtModify":1703739165398,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>Have been holding since Feb ","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>Have been holding since Feb ","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$Have been holding since Feb","images":[{"img":"https://static.tigerbbs.com/570612cd6514f7b5cb9efcf94dc5c7f5","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/156710833","isVote":1,"tweetType":1,"viewCount":1493,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":109549025,"gmtCreate":1619706741967,"gmtModify":1704271152015,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>wth is wrong w this ","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>wth is wrong w this ","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$wth is wrong w this","images":[{"img":"https://static.tigerbbs.com/346d4f7efb93d43c0da3a3de3ea167db","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/109549025","isVote":1,"tweetType":1,"viewCount":788,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":372200520,"gmtCreate":1619216534160,"gmtModify":1704721310790,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKK\">$ARK Innovation ETF(ARKK)$</a>Waiting for it to recover ","listText":"<a href=\"https://laohu8.com/S/ARKK\">$ARK Innovation ETF(ARKK)$</a>Waiting for it to recover ","text":"$ARK Innovation ETF(ARKK)$Waiting for it to recover","images":[{"img":"https://static.tigerbbs.com/3ebf96a80ddb9fc2608eda7e9369a1a2","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/372200520","isVote":1,"tweetType":1,"viewCount":1059,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":344626028,"gmtCreate":1618407464064,"gmtModify":1704710330598,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/CSCW\">$Color Star Technology Co. Ltd(CSCW)$</a>When will it go up ? ","listText":"<a href=\"https://laohu8.com/S/CSCW\">$Color Star Technology Co. Ltd(CSCW)$</a>When will it go up ? ","text":"$Color Star Technology Co. Ltd(CSCW)$When will it go up ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/344626028","isVote":1,"tweetType":1,"viewCount":757,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":345862782,"gmtCreate":1618301644546,"gmtModify":1704708793649,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"Nice ","listText":"Nice ","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/345862782","repostId":"1128427714","repostType":2,"isVote":1,"tweetType":1,"viewCount":549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":869909710,"gmtCreate":1632232781030,"gmtModify":1676530730510,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/VOO\">$Vanguard S&P 500 ETF(VOO)$</a>?","listText":"<a href=\"https://laohu8.com/S/VOO\">$Vanguard S&P 500 ETF(VOO)$</a>?","text":"$Vanguard S&P 500 ETF(VOO)$?","images":[{"img":"https://static.tigerbbs.com/3f37c53f199580d28bc2cf8dd6a9a33a","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/869909710","isVote":1,"tweetType":1,"viewCount":1754,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":172289826,"gmtCreate":1626962452465,"gmtModify":1703481468254,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>._. Have been holding since last year ","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>._. Have been holding since last year ","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$._. Have been holding since last year","images":[{"img":"https://static.tigerbbs.com/c807337cb85ef61d9bcd70f1b3161ee3","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/172289826","isVote":1,"tweetType":1,"viewCount":2101,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":141974061,"gmtCreate":1625837266653,"gmtModify":1703749529799,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"Good ","listText":"Good ","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141974061","repostId":"2150980376","repostType":4,"repost":{"id":"2150980376","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1625823947,"share":"https://ttm.financial/m/news/2150980376?lang=en_US&edition=fundamental","pubTime":"2021-07-09 17:45","market":"sh","language":"en","title":"China cuts reserve requirements to support economic recovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2150980376","media":"Reuters","summary":"BEIJING, July 9 (Reuters) - China's central bank said on Friday it would cut the amount of cash that","content":"<p>BEIJING, July 9 (Reuters) - China's central bank said on Friday it would cut the amount of cash that banks must hold as reserves, releasing around 1 trillion yuan ($154.19 billion) in long-term liquidity to help underpin an economic recovery that is starting to lose momentum.</p>\n<p>The People's Bank of China (PBOC) said on its website it would cut the reserve requirement ratio <a href=\"https://laohu8.com/S/RRR\">$(RRR)$</a> for all banks by 50 basis points (bps), effective on July 15.</p>\n<p>Banks that are subject to an RRR of 5% will be exempted from the new cut.</p>\n<p>The PBOC last cut the RRR in April last year, when the Chinese economy was still badly jolted by the coronavirus crisis. As the economy staged a strong rebound, aided by the surprisingly resilient exports, the PBOC had since shifted to a moderately tightening bias.</p>\n<p>The country's cabinet said on Wednesday that authorities will use timely cuts in RRR to help small firms cope with the negative impact from rising commodity prices, which came as a surprise to the market.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China cuts reserve requirements to support economic recovery</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina cuts reserve requirements to support economic recovery\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-09 17:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BEIJING, July 9 (Reuters) - China's central bank said on Friday it would cut the amount of cash that banks must hold as reserves, releasing around 1 trillion yuan ($154.19 billion) in long-term liquidity to help underpin an economic recovery that is starting to lose momentum.</p>\n<p>The People's Bank of China (PBOC) said on its website it would cut the reserve requirement ratio <a href=\"https://laohu8.com/S/RRR\">$(RRR)$</a> for all banks by 50 basis points (bps), effective on July 15.</p>\n<p>Banks that are subject to an RRR of 5% will be exempted from the new cut.</p>\n<p>The PBOC last cut the RRR in April last year, when the Chinese economy was still badly jolted by the coronavirus crisis. As the economy staged a strong rebound, aided by the surprisingly resilient exports, the PBOC had since shifted to a moderately tightening bias.</p>\n<p>The country's cabinet said on Wednesday that authorities will use timely cuts in RRR to help small firms cope with the negative impact from rising commodity prices, which came as a surprise to the market.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CAAS":"中汽系统","000001.SH":"上证指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2150980376","content_text":"BEIJING, July 9 (Reuters) - China's central bank said on Friday it would cut the amount of cash that banks must hold as reserves, releasing around 1 trillion yuan ($154.19 billion) in long-term liquidity to help underpin an economic recovery that is starting to lose momentum.\nThe People's Bank of China (PBOC) said on its website it would cut the reserve requirement ratio $(RRR)$ for all banks by 50 basis points (bps), effective on July 15.\nBanks that are subject to an RRR of 5% will be exempted from the new cut.\nThe PBOC last cut the RRR in April last year, when the Chinese economy was still badly jolted by the coronavirus crisis. As the economy staged a strong rebound, aided by the surprisingly resilient exports, the PBOC had since shifted to a moderately tightening bias.\nThe country's cabinet said on Wednesday that authorities will use timely cuts in RRR to help small firms cope with the negative impact from rising commodity prices, which came as a surprise to the market.","news_type":1,"symbols_score_info":{"000001.SH":0.9,"CAAS":0.9}},"isVote":1,"tweetType":1,"viewCount":1252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157137043,"gmtCreate":1625571578982,"gmtModify":1703743981828,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Fml ","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Fml ","text":"$Alibaba(BABA)$Fml","images":[{"img":"https://static.tigerbbs.com/c4795ba762ebdf7bb475df060911a49d","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/157137043","isVote":1,"tweetType":1,"viewCount":2199,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":125241091,"gmtCreate":1624677099313,"gmtModify":1703843431131,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>LOLOL finally less than 10% ","listText":"<a href=\"https://laohu8.com/S/ARKG\">$ARK Genomic Revolution Multi-Sector ETF(ARKG)$</a>LOLOL finally less than 10% ","text":"$ARK Genomic Revolution Multi-Sector ETF(ARKG)$LOLOL finally less than 10%","images":[{"img":"https://static.tigerbbs.com/6cf16fa79e2834e2fceb5d4dd2965904","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125241091","isVote":1,"tweetType":1,"viewCount":1392,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":103563501,"gmtCreate":1619793875303,"gmtModify":1704272506543,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"Nice ","listText":"Nice ","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/103563501","repostId":"1189807124","repostType":4,"repost":{"id":"1189807124","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1619791477,"share":"https://ttm.financial/m/news/1189807124?lang=en_US&edition=fundamental","pubTime":"2021-04-30 22:04","market":"us","language":"en","title":"Amazon once rose 2.4%, setting a record high in intraday trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1189807124","media":"Tiger Newspress","summary":"Amazon once rose 2.4%, setting a record high in intraday trading.Here’s what analysts are saying abo","content":"<p>Amazon once rose 2.4%, setting a record high in intraday trading.</p><p><img src=\"https://static.tigerbbs.com/9b9f7378d5970cada2dc37de1aa76935\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p>Here’s what analysts are saying about Amazon tripling profits</p><p>Swiss Bank UBS raises its price target as the COVID-19 pandemic caused boom in demand for home deliveries, helping Amazon triple profits</p><p>The COVID-19 pandemic has caused a boom in demand for home deliveries, which has helped AmazonAMZN,+1.75%triple its first-quarter profits.</p><p>The online retailer’s stock has risen 46% the past year and some analysts think it could still have further to go.</p><p>Michael Lasser, an analyst at Swiss bank UBSUBS,-0.92%,has lifted his price target for Amazon to $4,350 from $4,150, writing: “With broad-based strength across e-commerce & AWS, Amazon’s Q1 ’21 earnings report demonstrates why it remains the industry leader.”</p><p><b>Amazon’s pandemic profits top previous 3 years of earnings</b></p><p>Shyam Patil, an analyst from Susquehanna Financial Group, remains positive on Amazon.</p><p>“Business trends remain strong and should continue to do so throughout 2021,” he wrote. “Ultimately, we see AMZN as a long-term secular grower underpinned by its strong e-commerce, cloud, and advertising businesses.”</p><p><b>Should you buy Amazon stock? Analysts prefer it over other Big Tech companies</b></p><p>Trip Chowdhry, an analyst at Global Equities Research, noted the “solid results” and reiterated his view that Andy Jassy, who will replace founder Jeff Bezos as chief executive, will be a good boss.</p><p>Jassy currently runs Amazon Web Services, which Chowdhry says is benefiting from secular growth trends. “So many of you were panicked about CEO Transition,” he wrote. “Andy Jassy is a much better CEO than Jeff Bezos.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Amazon once rose 2.4%, setting a record high in intraday trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAmazon once rose 2.4%, setting a record high in intraday trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-04-30 22:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Amazon once rose 2.4%, setting a record high in intraday trading.</p><p><img src=\"https://static.tigerbbs.com/9b9f7378d5970cada2dc37de1aa76935\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p>Here’s what analysts are saying about Amazon tripling profits</p><p>Swiss Bank UBS raises its price target as the COVID-19 pandemic caused boom in demand for home deliveries, helping Amazon triple profits</p><p>The COVID-19 pandemic has caused a boom in demand for home deliveries, which has helped AmazonAMZN,+1.75%triple its first-quarter profits.</p><p>The online retailer’s stock has risen 46% the past year and some analysts think it could still have further to go.</p><p>Michael Lasser, an analyst at Swiss bank UBSUBS,-0.92%,has lifted his price target for Amazon to $4,350 from $4,150, writing: “With broad-based strength across e-commerce & AWS, Amazon’s Q1 ’21 earnings report demonstrates why it remains the industry leader.”</p><p><b>Amazon’s pandemic profits top previous 3 years of earnings</b></p><p>Shyam Patil, an analyst from Susquehanna Financial Group, remains positive on Amazon.</p><p>“Business trends remain strong and should continue to do so throughout 2021,” he wrote. “Ultimately, we see AMZN as a long-term secular grower underpinned by its strong e-commerce, cloud, and advertising businesses.”</p><p><b>Should you buy Amazon stock? Analysts prefer it over other Big Tech companies</b></p><p>Trip Chowdhry, an analyst at Global Equities Research, noted the “solid results” and reiterated his view that Andy Jassy, who will replace founder Jeff Bezos as chief executive, will be a good boss.</p><p>Jassy currently runs Amazon Web Services, which Chowdhry says is benefiting from secular growth trends. “So many of you were panicked about CEO Transition,” he wrote. “Andy Jassy is a much better CEO than Jeff Bezos.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMZN":"亚马逊"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189807124","content_text":"Amazon once rose 2.4%, setting a record high in intraday trading.Here’s what analysts are saying about Amazon tripling profitsSwiss Bank UBS raises its price target as the COVID-19 pandemic caused boom in demand for home deliveries, helping Amazon triple profitsThe COVID-19 pandemic has caused a boom in demand for home deliveries, which has helped AmazonAMZN,+1.75%triple its first-quarter profits.The online retailer’s stock has risen 46% the past year and some analysts think it could still have further to go.Michael Lasser, an analyst at Swiss bank UBSUBS,-0.92%,has lifted his price target for Amazon to $4,350 from $4,150, writing: “With broad-based strength across e-commerce & AWS, Amazon’s Q1 ’21 earnings report demonstrates why it remains the industry leader.”Amazon’s pandemic profits top previous 3 years of earningsShyam Patil, an analyst from Susquehanna Financial Group, remains positive on Amazon.“Business trends remain strong and should continue to do so throughout 2021,” he wrote. “Ultimately, we see AMZN as a long-term secular grower underpinned by its strong e-commerce, cloud, and advertising businesses.”Should you buy Amazon stock? Analysts prefer it over other Big Tech companiesTrip Chowdhry, an analyst at Global Equities Research, noted the “solid results” and reiterated his view that Andy Jassy, who will replace founder Jeff Bezos as chief executive, will be a good boss.Jassy currently runs Amazon Web Services, which Chowdhry says is benefiting from secular growth trends. “So many of you were panicked about CEO Transition,” he wrote. “Andy Jassy is a much better CEO than Jeff Bezos.”","news_type":1,"symbols_score_info":{"AMZN":0.9}},"isVote":1,"tweetType":1,"viewCount":536,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103587581,"gmtCreate":1619793707443,"gmtModify":1704272502269,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"Nice ","listText":"Nice ","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/103587581","repostId":"1165708828","repostType":4,"repost":{"id":"1165708828","kind":"news","pubTimestamp":1619792862,"share":"https://ttm.financial/m/news/1165708828?lang=en_US&edition=fundamental","pubTime":"2021-04-30 22:27","market":"us","language":"en","title":"3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=1165708828","media":"Motley Fool","summary":"For more than a year, patient investors have been handsomely rewarded. All three of the market's maj","content":"<p>For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, 2020.</p>\n<p>Yet, not all stocks have participated in the rally. Over the trailing year (through April 27, 2021), around 110 stocks with at least a $300 million market cap have declined by 20% (or more). Given the aforementioned big gains in the<b>S&P 500</b>,<b>Dow Jones Industrial Average</b>, and<b>Nasdaq Composite</b>, this represents a huge underperformance.</p>\n<p>But according to analysts on Wall Street, some of these underperformers have a good chance to bounce back in a big way over the coming year. Based on consensus one-year price targets, the following three turnaround stocks offer upside ranging from 91% to as much as 104%.</p>\n<p>Sarepta Therapeutics: Implied upside of 91%</p>\n<p>Many of the worst-performing equities over the past year arebiotech stocks. With investors rolling the dice on future clinical outcomes, trial data announcements can yield wild price swings for drug developers. Shareholders of specialized drug developer<b>Sarepta Therapeutics</b>(NASDAQ:SRPT)learned this in January when shares of the company were halved in a day. But if Wall Street's one-year price target is correct, Sarepta could recoup most of its losses by gaining 91% from its April 27 close.</p>\n<p>Sarepta's bread and butter is its research in treating Duchenne Muscular Dystrophy (DMD). DMD is an incurable disease diagnosed in children that leads to the destruction of muscle and causes premature death. To date, the company has had the U.S. Food and Drug Administration (FDA) approve three of its gene-specific DMD treatments, which are designed to increase the production of dystrophin.</p>\n<p>However, themake-or-break treatmentin the company's pipeline is SRP-9001. This is an experimental treatment that utilizes an adeno-associated virus to deliver a gene to muscle tissue that \"programs\" for micro-dystrophin production. In other words, SRP-9001 would allow the company to treat a much larger percentage of DMD patients.</p>\n<p>The Part 1 data release of Study 102 evaluating SRP-9001 in DMD patients aged 4 to 7 is why the stock was halved in January. Although treated participants showed an increase in their North Star Ambulatory Assessment (NSAA) total score,it wasn't statistically significant. Sarepta, however, blamed this disappointment on fitness differences in its patients during the study and expects a much different outcome in the latter half of this study. Part 2 of Study 102 is, therefore, Sarepta's make-or-break DMD moment.</p>\n<p>Intercept Pharmaceuticals: Implied upside of 97%</p>\n<p>If you wanteven more upside potential, Wall Street would steer you toward small-cap<b>Intercept Pharmaceuticals</b>(NASDAQ:ICPT). Among the 4,000-plus securities with at least a $300 million market cap, it holds the distinction of being the absolute worst performer over the trailing year (down 75%). The only solace is that Wall Street's consensus price target would see Intercept gain 97% over the coming year.</p>\n<p>Similar to Sarepta, Intercept's future predominantly lies with one indication: nonalcoholic steatohepatitis, or NASH. NASH is a liver disease that affects between 2% and 5% of the U.S. adult population and has no FDA-approved cure. It can lead to fibrosis, liver cancer, and even death. It's been estimated that NASH represents a $35 billion treatment opportunity.</p>\n<p>Intercept is at the forefront of that opportunity, but it's not been without its hiccups. Experimental treatment obeticholic acid (OCA)met one of its two co-primary endpointsin the phase 3 Regenerate study -- a statistically significant reduction in liver fibrosis without a worsening in NASH. Only one met endpoint was needed to declare the trial a success.</p>\n<p>On the other hand, the highest dose (also the most effective) led to considerably higher instances of pruritus (itching) and trial discontinuation, relative to the placebo. Perhaps unsurprisingly, Interceptreceived a Complete Response Letterfrom the FDA following its new drug application to supply additional safety data.</p>\n<p>If OCA were to be approved, even for a small subset of the sickest patients, it would represent a greater than $1 billion sales opportunity.</p>\n<p>It's also worth noting that OCA is already approved under the brand name Ocaliva as a treatment for primary biliary cholangitis (PBC). With Ocaliva's PBC sales expected to hit at least $325 million in 2021 (nearly half the company's market cap), investors look to begetting a shot at NASH success nearly for free.</p>\n<p>Inovio Pharmaceuticals: Implied upside of 104%</p>\n<p>Yet another biotech stock withbig-time upside potential, according to Wall Street, is<b>Inovio Pharmaceuticals</b>(NASDAQ:INO). Shares of the company have been clobbered recently, but are expected to rally by 104% to nearly $15 based on the consensus 12-month price target of analysts.</p>\n<p>For much of the past year, the promise and peril of Inovio have rested with its development of a coronavirus disease 2019 (COVID-19) vaccine. The company's candidate, INO-4800, achieved immunological responses in 38 of 38 patients in phase 1 studies and looked to be on track to be among the roughly six or so early contenders to bring a COVID-19 vaccine to market in the United States.</p>\n<p>Unfortunately, Inovio's phase 2 and 3 studies hit a snag. The FDA placed a partial clinical hold on both phases and requested additional information concerning INO-4800 and the company's Cellectra delivery device. Cellectra uses electrical impulses to open pores in cells to allow plasmids to enter. Though the partial hold on the phase 2 study was lifted, the company has yet to run an all-important phase 3 study and may choose to do so outside the United States. To top things off, the U.S. Department of Defense notified Inovio that it wouldno longer be providing funding for its phase 3 study.</p>\n<p>There are two very big problems here. First, Inovio is running out of time to become a major player in treating COVID-19. The U.S. vaccination campaign will likely be complete sometime in July, and major players like<b>Johnson & Johnson</b> can produce up to 3 billion doses for the global market this year. As a reminder, J&J's vaccine is a single-dose treatment.</p>\n<p>The other potential red flag isInovio's track record. The company may have an intriguing delivery device in Cellectra, as well as nearly a dozen unique compounds in clinical trials, but it's yet to have the FDA approve any of its experimental treatments in four decades.</p>\n<p>With a number of its studies partnered, it's always possible Inovio could turn itself around. But given its track record, it may be best off avoided.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Turnaround Stocks With 91% to 104% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-30 22:27 GMT+8 <a href=https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/04/30/3-turnaround-stocks-91-to-104-upside-wall-street/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165708828","content_text":"For more than a year, patient investors have been handsomely rewarded. All three of the market's major indexes have gained between 83% and 106% since hitting the bear-market bottom set on March 23, 2020.\nYet, not all stocks have participated in the rally. Over the trailing year (through April 27, 2021), around 110 stocks with at least a $300 million market cap have declined by 20% (or more). Given the aforementioned big gains in theS&P 500,Dow Jones Industrial Average, andNasdaq Composite, this represents a huge underperformance.\nBut according to analysts on Wall Street, some of these underperformers have a good chance to bounce back in a big way over the coming year. Based on consensus one-year price targets, the following three turnaround stocks offer upside ranging from 91% to as much as 104%.\nSarepta Therapeutics: Implied upside of 91%\nMany of the worst-performing equities over the past year arebiotech stocks. With investors rolling the dice on future clinical outcomes, trial data announcements can yield wild price swings for drug developers. Shareholders of specialized drug developerSarepta Therapeutics(NASDAQ:SRPT)learned this in January when shares of the company were halved in a day. But if Wall Street's one-year price target is correct, Sarepta could recoup most of its losses by gaining 91% from its April 27 close.\nSarepta's bread and butter is its research in treating Duchenne Muscular Dystrophy (DMD). DMD is an incurable disease diagnosed in children that leads to the destruction of muscle and causes premature death. To date, the company has had the U.S. Food and Drug Administration (FDA) approve three of its gene-specific DMD treatments, which are designed to increase the production of dystrophin.\nHowever, themake-or-break treatmentin the company's pipeline is SRP-9001. This is an experimental treatment that utilizes an adeno-associated virus to deliver a gene to muscle tissue that \"programs\" for micro-dystrophin production. In other words, SRP-9001 would allow the company to treat a much larger percentage of DMD patients.\nThe Part 1 data release of Study 102 evaluating SRP-9001 in DMD patients aged 4 to 7 is why the stock was halved in January. Although treated participants showed an increase in their North Star Ambulatory Assessment (NSAA) total score,it wasn't statistically significant. Sarepta, however, blamed this disappointment on fitness differences in its patients during the study and expects a much different outcome in the latter half of this study. Part 2 of Study 102 is, therefore, Sarepta's make-or-break DMD moment.\nIntercept Pharmaceuticals: Implied upside of 97%\nIf you wanteven more upside potential, Wall Street would steer you toward small-capIntercept Pharmaceuticals(NASDAQ:ICPT). Among the 4,000-plus securities with at least a $300 million market cap, it holds the distinction of being the absolute worst performer over the trailing year (down 75%). The only solace is that Wall Street's consensus price target would see Intercept gain 97% over the coming year.\nSimilar to Sarepta, Intercept's future predominantly lies with one indication: nonalcoholic steatohepatitis, or NASH. NASH is a liver disease that affects between 2% and 5% of the U.S. adult population and has no FDA-approved cure. It can lead to fibrosis, liver cancer, and even death. It's been estimated that NASH represents a $35 billion treatment opportunity.\nIntercept is at the forefront of that opportunity, but it's not been without its hiccups. Experimental treatment obeticholic acid (OCA)met one of its two co-primary endpointsin the phase 3 Regenerate study -- a statistically significant reduction in liver fibrosis without a worsening in NASH. Only one met endpoint was needed to declare the trial a success.\nOn the other hand, the highest dose (also the most effective) led to considerably higher instances of pruritus (itching) and trial discontinuation, relative to the placebo. Perhaps unsurprisingly, Interceptreceived a Complete Response Letterfrom the FDA following its new drug application to supply additional safety data.\nIf OCA were to be approved, even for a small subset of the sickest patients, it would represent a greater than $1 billion sales opportunity.\nIt's also worth noting that OCA is already approved under the brand name Ocaliva as a treatment for primary biliary cholangitis (PBC). With Ocaliva's PBC sales expected to hit at least $325 million in 2021 (nearly half the company's market cap), investors look to begetting a shot at NASH success nearly for free.\nInovio Pharmaceuticals: Implied upside of 104%\nYet another biotech stock withbig-time upside potential, according to Wall Street, isInovio Pharmaceuticals(NASDAQ:INO). Shares of the company have been clobbered recently, but are expected to rally by 104% to nearly $15 based on the consensus 12-month price target of analysts.\nFor much of the past year, the promise and peril of Inovio have rested with its development of a coronavirus disease 2019 (COVID-19) vaccine. The company's candidate, INO-4800, achieved immunological responses in 38 of 38 patients in phase 1 studies and looked to be on track to be among the roughly six or so early contenders to bring a COVID-19 vaccine to market in the United States.\nUnfortunately, Inovio's phase 2 and 3 studies hit a snag. The FDA placed a partial clinical hold on both phases and requested additional information concerning INO-4800 and the company's Cellectra delivery device. Cellectra uses electrical impulses to open pores in cells to allow plasmids to enter. Though the partial hold on the phase 2 study was lifted, the company has yet to run an all-important phase 3 study and may choose to do so outside the United States. To top things off, the U.S. Department of Defense notified Inovio that it wouldno longer be providing funding for its phase 3 study.\nThere are two very big problems here. First, Inovio is running out of time to become a major player in treating COVID-19. The U.S. vaccination campaign will likely be complete sometime in July, and major players likeJohnson & Johnson can produce up to 3 billion doses for the global market this year. As a reminder, J&J's vaccine is a single-dose treatment.\nThe other potential red flag isInovio's track record. The company may have an intriguing delivery device in Cellectra, as well as nearly a dozen unique compounds in clinical trials, but it's yet to have the FDA approve any of its experimental treatments in four decades.\nWith a number of its studies partnered, it's always possible Inovio could turn itself around. But given its track record, it may be best off avoided.","news_type":1,"symbols_score_info":{}},"isVote":1,"tweetType":1,"viewCount":579,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":103587837,"gmtCreate":1619793694329,"gmtModify":1704272501779,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"Nice ","listText":"Nice ","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/103587837","repostId":"1142070002","repostType":4,"repost":{"id":"1142070002","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1619792975,"share":"https://ttm.financial/m/news/1142070002?lang=en_US&edition=fundamental","pubTime":"2021-04-30 22:29","market":"us","language":"en","title":"NIO rose more than 5%, after falling nearly 4% before","url":"https://stock-news.laohu8.com/highlight/detail?id=1142070002","media":"Tiger Newspress","summary":"NIO Earnings Looked a Lot Like Ford’s. What to Know.Chinese electric vehicle maker NIO posted better than expected first quarter results. But the global automotive microchip shortage will hit production in the coming months.NIO is a highly valued, high-growth stock. Now NIO bulls have to decide whether solid earnings will trump the growth hiccup or whether the chip shortage can hurt the company in the long run.NIO lost 23 cents a share on an adjusted, non-GAAP basis, from $1.2 billion in sales.","content":"<p>NIO rose more than 5%, after falling nearly 4% before.</p><p><img src=\"https://static.tigerbbs.com/80881ae9e6de48ac5e3733583db3ba9e\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p><b>NIO Earnings Looked a Lot Like Ford’s. What to Know.</b></p><p>Chinese electric vehicle maker NIO posted better than expected first quarter results. But the global automotive microchip shortage will hit production in the coming months.</p><p>NIO (ticker: NIO) is a highly valued, high-growth stock. Now NIO bulls have to decide whether solid earnings will trump the growth hiccup or whether the chip shortage can hurt the company in the long run.</p><p>NIO lost 23 cents a share on an adjusted, non-GAAP basis, from $1.2 billion in sales. Wall Street was looking for a comparable 84 cent loss from $1.1 billion in sales. NIO’s corporate gross profit margin came in at 19.5%, about 3 percentage points better than analysts projected and up from negative 12% a year ago. First quarter results look solid.</p><p>The stock isn’t moving though. NIO reported numbers at 5:30 p.m. eastern time and not a lot of stock is trading after hours. NIO shares closed down 5.3% in Thursday trading. TheS&P 500 and Dow Jones Industrial Average rose about 0.7%.</p><p>“NIO started the year of 2021 with a new quarterly delivery record of 20,060 vehicles in the first quarter,” said CEO William Bin Li in the company’s news release. “The overall demand for our products continues to be quite strong, but the supply chain is still facing significant challenges due to the semiconductor shortage.”</p><p>Management called the chip situation “very severe” on its conference call and projected 21,000 to 22,000 vehicle deliveries for the second quarter and sales of about $1.3 billion. The Street is projecting $1.2 billion in sales. But the unit delivery guidance is a little lower than Deutsche Bank analyst Edison Yu had expected.</p><p>For the full year, Yu is modeling 95,000 deliveries. With about 42,000 deliveries likely for the first half of 2021, the resolution of the global chip shortage will go a long way to deciding whether or not NIO can reach Yu’s number.</p><p>Yu rates NIO shares Buy and has a $60 price target for the stock.</p><p>The overall quarter feels a little like Ford Motor‘s (F) quarter, which was reported Wednesday. Ford reported sales and earnings far better than Wall Street projected. Unit volumes were below the company’s internal projections, but improving vehicle mix boosted sales beyond Street projections. Ford prioritized making higher-end vehicles in the face of limited chip supply. Looking ahead, Ford said the impact of the chip shortage would be at the high end of the company’s initial $1 billion to $2.5 billion cost guidance.</p><p>Ford stock close down 9.4% Thursday, the day after the Wednesday evening report. The NIO second-quarter guidance isn’t as surprising as Ford’s. And NIO doesn’t have full-year guidance. But calling NIO’s stock price reaction is difficult.</p><p>Ford trades for less than 7 times estimated 2022 earnings. NIO is expected to become profitable on a full-year basis in 2022. What’s more, NIO is worth about 50% more than Ford.</p><p>NIO’s conference call wrapped up about 10 p.m. eastern time. After the chip shortage, analysts focused questions on EV competition in China and NIO’s production expansion. NIO is putting in place capacity to produce hundreds of thousands of vehicles in coming years.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>NIO rose more than 5%, after falling nearly 4% before</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNIO rose more than 5%, after falling nearly 4% before\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-04-30 22:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NIO rose more than 5%, after falling nearly 4% before.</p><p><img src=\"https://static.tigerbbs.com/80881ae9e6de48ac5e3733583db3ba9e\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p><p><b>NIO Earnings Looked a Lot Like Ford’s. What to Know.</b></p><p>Chinese electric vehicle maker NIO posted better than expected first quarter results. But the global automotive microchip shortage will hit production in the coming months.</p><p>NIO (ticker: NIO) is a highly valued, high-growth stock. Now NIO bulls have to decide whether solid earnings will trump the growth hiccup or whether the chip shortage can hurt the company in the long run.</p><p>NIO lost 23 cents a share on an adjusted, non-GAAP basis, from $1.2 billion in sales. Wall Street was looking for a comparable 84 cent loss from $1.1 billion in sales. NIO’s corporate gross profit margin came in at 19.5%, about 3 percentage points better than analysts projected and up from negative 12% a year ago. First quarter results look solid.</p><p>The stock isn’t moving though. NIO reported numbers at 5:30 p.m. eastern time and not a lot of stock is trading after hours. NIO shares closed down 5.3% in Thursday trading. TheS&P 500 and Dow Jones Industrial Average rose about 0.7%.</p><p>“NIO started the year of 2021 with a new quarterly delivery record of 20,060 vehicles in the first quarter,” said CEO William Bin Li in the company’s news release. “The overall demand for our products continues to be quite strong, but the supply chain is still facing significant challenges due to the semiconductor shortage.”</p><p>Management called the chip situation “very severe” on its conference call and projected 21,000 to 22,000 vehicle deliveries for the second quarter and sales of about $1.3 billion. The Street is projecting $1.2 billion in sales. But the unit delivery guidance is a little lower than Deutsche Bank analyst Edison Yu had expected.</p><p>For the full year, Yu is modeling 95,000 deliveries. With about 42,000 deliveries likely for the first half of 2021, the resolution of the global chip shortage will go a long way to deciding whether or not NIO can reach Yu’s number.</p><p>Yu rates NIO shares Buy and has a $60 price target for the stock.</p><p>The overall quarter feels a little like Ford Motor‘s (F) quarter, which was reported Wednesday. Ford reported sales and earnings far better than Wall Street projected. Unit volumes were below the company’s internal projections, but improving vehicle mix boosted sales beyond Street projections. Ford prioritized making higher-end vehicles in the face of limited chip supply. Looking ahead, Ford said the impact of the chip shortage would be at the high end of the company’s initial $1 billion to $2.5 billion cost guidance.</p><p>Ford stock close down 9.4% Thursday, the day after the Wednesday evening report. The NIO second-quarter guidance isn’t as surprising as Ford’s. And NIO doesn’t have full-year guidance. But calling NIO’s stock price reaction is difficult.</p><p>Ford trades for less than 7 times estimated 2022 earnings. NIO is expected to become profitable on a full-year basis in 2022. What’s more, NIO is worth about 50% more than Ford.</p><p>NIO’s conference call wrapped up about 10 p.m. eastern time. After the chip shortage, analysts focused questions on EV competition in China and NIO’s production expansion. NIO is putting in place capacity to produce hundreds of thousands of vehicles in coming years.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142070002","content_text":"NIO rose more than 5%, after falling nearly 4% before.NIO Earnings Looked a Lot Like Ford’s. What to Know.Chinese electric vehicle maker NIO posted better than expected first quarter results. But the global automotive microchip shortage will hit production in the coming months.NIO (ticker: NIO) is a highly valued, high-growth stock. Now NIO bulls have to decide whether solid earnings will trump the growth hiccup or whether the chip shortage can hurt the company in the long run.NIO lost 23 cents a share on an adjusted, non-GAAP basis, from $1.2 billion in sales. Wall Street was looking for a comparable 84 cent loss from $1.1 billion in sales. NIO’s corporate gross profit margin came in at 19.5%, about 3 percentage points better than analysts projected and up from negative 12% a year ago. First quarter results look solid.The stock isn’t moving though. NIO reported numbers at 5:30 p.m. eastern time and not a lot of stock is trading after hours. NIO shares closed down 5.3% in Thursday trading. TheS&P 500 and Dow Jones Industrial Average rose about 0.7%.“NIO started the year of 2021 with a new quarterly delivery record of 20,060 vehicles in the first quarter,” said CEO William Bin Li in the company’s news release. “The overall demand for our products continues to be quite strong, but the supply chain is still facing significant challenges due to the semiconductor shortage.”Management called the chip situation “very severe” on its conference call and projected 21,000 to 22,000 vehicle deliveries for the second quarter and sales of about $1.3 billion. The Street is projecting $1.2 billion in sales. But the unit delivery guidance is a little lower than Deutsche Bank analyst Edison Yu had expected.For the full year, Yu is modeling 95,000 deliveries. With about 42,000 deliveries likely for the first half of 2021, the resolution of the global chip shortage will go a long way to deciding whether or not NIO can reach Yu’s number.Yu rates NIO shares Buy and has a $60 price target for the stock.The overall quarter feels a little like Ford Motor‘s (F) quarter, which was reported Wednesday. Ford reported sales and earnings far better than Wall Street projected. Unit volumes were below the company’s internal projections, but improving vehicle mix boosted sales beyond Street projections. Ford prioritized making higher-end vehicles in the face of limited chip supply. Looking ahead, Ford said the impact of the chip shortage would be at the high end of the company’s initial $1 billion to $2.5 billion cost guidance.Ford stock close down 9.4% Thursday, the day after the Wednesday evening report. The NIO second-quarter guidance isn’t as surprising as Ford’s. And NIO doesn’t have full-year guidance. But calling NIO’s stock price reaction is difficult.Ford trades for less than 7 times estimated 2022 earnings. NIO is expected to become profitable on a full-year basis in 2022. What’s more, NIO is worth about 50% more than Ford.NIO’s conference call wrapped up about 10 p.m. eastern time. After the chip shortage, analysts focused questions on EV competition in China and NIO’s production expansion. NIO is putting in place capacity to produce hundreds of thousands of vehicles in coming years.","news_type":1,"symbols_score_info":{"NIO":0.9}},"isVote":1,"tweetType":1,"viewCount":774,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":141977194,"gmtCreate":1625837339818,"gmtModify":1703749531267,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"Nice ","listText":"Nice ","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141977194","repostId":"2150376848","repostType":4,"repost":{"id":"2150376848","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1625821544,"share":"https://ttm.financial/m/news/2150376848?lang=en_US&edition=fundamental","pubTime":"2021-07-09 17:05","market":"hk","language":"en","title":"China June new bank loans rise to 2.12 trln yuan, beat expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2150376848","media":"Reuters","summary":"BEIJING, July 9 (Reuters) - Chinese banks extended 2.12 trillion yuan ($327 billion) in new yuan loa","content":"<p>BEIJING, July 9 (Reuters) - Chinese banks extended 2.12 trillion yuan ($327 billion) in new yuan loans in June, up from May and exceeding analysts' expectations.</p>\n<p>Analysts polled by Reuters had predicted new yuan loans would rise to 1.8 trillion yuan in June from 1.5 trillion yuan the previous month and against 1.81 trillion yuan a year earlier.</p>\n<p>Broad M2 money supply grew 8.6% from a year earlier, central bank data showed on Friday, also above estimates of 8.2% forecast in the Reuters poll. M2 grew 8.3% in May from a year ago.</p>\n<p>Outstanding yuan loans grew 12.3% from a year earlier compared with 12.2% growth in May. Analysts had expected 12.1% growth.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China June new bank loans rise to 2.12 trln yuan, beat expectations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina June new bank loans rise to 2.12 trln yuan, beat expectations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-09 17:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BEIJING, July 9 (Reuters) - Chinese banks extended 2.12 trillion yuan ($327 billion) in new yuan loans in June, up from May and exceeding analysts' expectations.</p>\n<p>Analysts polled by Reuters had predicted new yuan loans would rise to 1.8 trillion yuan in June from 1.5 trillion yuan the previous month and against 1.81 trillion yuan a year earlier.</p>\n<p>Broad M2 money supply grew 8.6% from a year earlier, central bank data showed on Friday, also above estimates of 8.2% forecast in the Reuters poll. M2 grew 8.3% in May from a year ago.</p>\n<p>Outstanding yuan loans grew 12.3% from a year earlier compared with 12.2% growth in May. Analysts had expected 12.1% growth.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CAAS":"中汽系统"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2150376848","content_text":"BEIJING, July 9 (Reuters) - Chinese banks extended 2.12 trillion yuan ($327 billion) in new yuan loans in June, up from May and exceeding analysts' expectations.\nAnalysts polled by Reuters had predicted new yuan loans would rise to 1.8 trillion yuan in June from 1.5 trillion yuan the previous month and against 1.81 trillion yuan a year earlier.\nBroad M2 money supply grew 8.6% from a year earlier, central bank data showed on Friday, also above estimates of 8.2% forecast in the Reuters poll. M2 grew 8.3% in May from a year ago.\nOutstanding yuan loans grew 12.3% from a year earlier compared with 12.2% growth in May. Analysts had expected 12.1% growth.","news_type":1,"symbols_score_info":{"CAAS":0.9}},"isVote":1,"tweetType":1,"viewCount":1801,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":141977009,"gmtCreate":1625837311701,"gmtModify":1703749530451,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"Oh noooo","listText":"Oh noooo","text":"Oh noooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141977009","repostId":"2150537517","repostType":4,"repost":{"id":"2150537517","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1625821315,"share":"https://ttm.financial/m/news/2150537517?lang=en_US&edition=fundamental","pubTime":"2021-07-09 17:01","market":"hk","language":"en","title":"Hong Kong stocks post worst week in over 4 months on tech rout","url":"https://stock-news.laohu8.com/highlight/detail?id=2150537517","media":"Reuters","summary":"* HK->Shanghai Connect daily quota used 2.9%, Shanghai->HK daily quota used 6.9%\n* HSI +0.7%, HSCE +","content":"<p>* HK->Shanghai Connect daily quota used 2.9%, Shanghai->HK daily quota used 6.9%</p>\n<p>* HSI +0.7%, HSCE +0.6%, CSI300 -0.4%</p>\n<p>* FTSE China A50 -0.6%</p>\n<p>July 9 (Reuters) - Hong Kong stocks rose on Friday after eight straight sessions of falls, but marked their worst week in more than four months due to a tech rout fuelled by regulatory concerns.</p>\n<p>** The Hang Seng index rose 0.7% to 27,344.54, while the China Enterprises Index gained 0.6% to 9,885.42.</p>\n<p>** For the week, HSI dropped 3.4% and HSCE slumped 5.1%, both posting their worst week since late February.</p>\n<p>** The Hang Seng tech index hit a nine-month low before reversing course to end 1.5% higher, helped by bargain hunting.</p>\n<p>** The index has tumbled more than 30% from a record high hit in mid-February, as Beijing stepped up regulatory pressure on the country's tech giants and platform companies.</p>\n<p>** China's securities regulator is setting up a team to review plans by Chinese companies for initial public offerings (IPOs) abroad.</p>\n<p>** On Wednesday, China's market regulator said it had fined a number of internet companies including Didi Chuxing , Tencent and Alibaba for failing to report earlier merger and acquisition deals for approval.</p>\n<p>** That came after China's cyberspace regulator said on Sunday that it had ordered smartphone app stores to stop offering Didi Global Inc's app after finding that the ride-hailing giant had illegally collected users' personal data.</p>\n<p>** Also weighing on sentiment were the latest headlines on Sino-U.S. tensions.</p>\n<p>** The Biden administration is set as early as Friday to add more than 10 Chinese companies to its economic blacklist over alleged human rights abuses and high-tech surveillance in Xinjiang, two sources told Reuters.</p>\n<p>** Late on Wednesday, the S&P Dow Jones Indices and FTSE Russell decided to remove more Chinese companies from their indices after an updated U.S. executive order barred domestic investment in firms with alleged ties to China's military.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong stocks post worst week in over 4 months on tech rout</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong stocks post worst week in over 4 months on tech rout\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-09 17:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* HK->Shanghai Connect daily quota used 2.9%, Shanghai->HK daily quota used 6.9%</p>\n<p>* HSI +0.7%, HSCE +0.6%, CSI300 -0.4%</p>\n<p>* FTSE China A50 -0.6%</p>\n<p>July 9 (Reuters) - Hong Kong stocks rose on Friday after eight straight sessions of falls, but marked their worst week in more than four months due to a tech rout fuelled by regulatory concerns.</p>\n<p>** The Hang Seng index rose 0.7% to 27,344.54, while the China Enterprises Index gained 0.6% to 9,885.42.</p>\n<p>** For the week, HSI dropped 3.4% and HSCE slumped 5.1%, both posting their worst week since late February.</p>\n<p>** The Hang Seng tech index hit a nine-month low before reversing course to end 1.5% higher, helped by bargain hunting.</p>\n<p>** The index has tumbled more than 30% from a record high hit in mid-February, as Beijing stepped up regulatory pressure on the country's tech giants and platform companies.</p>\n<p>** China's securities regulator is setting up a team to review plans by Chinese companies for initial public offerings (IPOs) abroad.</p>\n<p>** On Wednesday, China's market regulator said it had fined a number of internet companies including Didi Chuxing , Tencent and Alibaba for failing to report earlier merger and acquisition deals for approval.</p>\n<p>** That came after China's cyberspace regulator said on Sunday that it had ordered smartphone app stores to stop offering Didi Global Inc's app after finding that the ride-hailing giant had illegally collected users' personal data.</p>\n<p>** Also weighing on sentiment were the latest headlines on Sino-U.S. tensions.</p>\n<p>** The Biden administration is set as early as Friday to add more than 10 Chinese companies to its economic blacklist over alleged human rights abuses and high-tech surveillance in Xinjiang, two sources told Reuters.</p>\n<p>** Late on Wednesday, the S&P Dow Jones Indices and FTSE Russell decided to remove more Chinese companies from their indices after an updated U.S. executive order barred domestic investment in firms with alleged ties to China's military.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QNETCN":"纳斯达克中美互联网老虎指数","09988":"阿里巴巴-W","HSI":"恒生指数"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2150537517","content_text":"* HK->Shanghai Connect daily quota used 2.9%, Shanghai->HK daily quota used 6.9%\n* HSI +0.7%, HSCE +0.6%, CSI300 -0.4%\n* FTSE China A50 -0.6%\nJuly 9 (Reuters) - Hong Kong stocks rose on Friday after eight straight sessions of falls, but marked their worst week in more than four months due to a tech rout fuelled by regulatory concerns.\n** The Hang Seng index rose 0.7% to 27,344.54, while the China Enterprises Index gained 0.6% to 9,885.42.\n** For the week, HSI dropped 3.4% and HSCE slumped 5.1%, both posting their worst week since late February.\n** The Hang Seng tech index hit a nine-month low before reversing course to end 1.5% higher, helped by bargain hunting.\n** The index has tumbled more than 30% from a record high hit in mid-February, as Beijing stepped up regulatory pressure on the country's tech giants and platform companies.\n** China's securities regulator is setting up a team to review plans by Chinese companies for initial public offerings (IPOs) abroad.\n** On Wednesday, China's market regulator said it had fined a number of internet companies including Didi Chuxing , Tencent and Alibaba for failing to report earlier merger and acquisition deals for approval.\n** That came after China's cyberspace regulator said on Sunday that it had ordered smartphone app stores to stop offering Didi Global Inc's app after finding that the ride-hailing giant had illegally collected users' personal data.\n** Also weighing on sentiment were the latest headlines on Sino-U.S. tensions.\n** The Biden administration is set as early as Friday to add more than 10 Chinese companies to its economic blacklist over alleged human rights abuses and high-tech surveillance in Xinjiang, two sources told Reuters.\n** Late on Wednesday, the S&P Dow Jones Indices and FTSE Russell decided to remove more Chinese companies from their indices after an updated U.S. executive order barred domestic investment in firms with alleged ties to China's military.","news_type":1,"symbols_score_info":{"QNETCN":0.9,"HSI":0.9,"09988":0.9}},"isVote":1,"tweetType":1,"viewCount":2016,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":141974483,"gmtCreate":1625837295442,"gmtModify":1703749531105,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"Kkkk ","listText":"Kkkk ","text":"Kkkk","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/141974483","repostId":"1113072261","repostType":4,"repost":{"id":"1113072261","kind":"news","pubTimestamp":1625823554,"share":"https://ttm.financial/m/news/1113072261?lang=en_US&edition=fundamental","pubTime":"2021-07-09 17:39","market":"us","language":"en","title":"GameStop Short Seller Melvin Capital Ended 2021 First-Half With 46% Loss: Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1113072261","media":"Benzinga","summary":"GameStop Corp. short seller Melvin Capital Management LP ended the first half of 2021 with a loss of","content":"<div>\n<p>GameStop Corp. short seller Melvin Capital Management LP ended the first half of 2021 with a loss of 46%, Bloomberg reported Thursday, citing people familiar with the matter.\nWhat Happened:Founded in ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/07/21909875/gamestop-short-seller-melvin-capital-ended-2021-first-half-with-46-loss-report\">Source Link</a>\n\n</div>\n","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GameStop Short Seller Melvin Capital Ended 2021 First-Half With 46% Loss: Report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGameStop Short Seller Melvin Capital Ended 2021 First-Half With 46% Loss: Report\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-09 17:39 GMT+8 <a href=https://www.benzinga.com/news/21/07/21909875/gamestop-short-seller-melvin-capital-ended-2021-first-half-with-46-loss-report><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>GameStop Corp. short seller Melvin Capital Management LP ended the first half of 2021 with a loss of 46%, Bloomberg reported Thursday, citing people familiar with the matter.\nWhat Happened:Founded in ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/07/21909875/gamestop-short-seller-melvin-capital-ended-2021-first-half-with-46-loss-report\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GME":"游戏驿站","AMC":"AMC院线"},"source_url":"https://www.benzinga.com/news/21/07/21909875/gamestop-short-seller-melvin-capital-ended-2021-first-half-with-46-loss-report","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113072261","content_text":"GameStop Corp. short seller Melvin Capital Management LP ended the first half of 2021 with a loss of 46%, Bloomberg reported Thursday, citing people familiar with the matter.\nWhat Happened:Founded in 2014 by Gabe Plotkin, a former portfolio manager for Steve Cohen, Melvin Capital was at the heart of the GameStop saga earlier this year.\nThe hedge fund, which managed $11 billion in assets as of June 1, is taking smaller-sized positions to limit exposure to single companies, as per the report.\nPlotkin has reportedly instructed his team of data scientists to watch social media and message boards to look for shares that are seeing high support from retail investors.\nWhy It Matters:Melvin Capital’s first-half results indicate the hedge fund is struggling to rebound from thelossesit incurred from betting against GameStop and other stonks - stocks popular with retail investors.\nMelvin Capital said in May it has closed out of all its public bearish positions in the first quarter. This included its listed put options in GameStop.\nIt was reported in June that London-based White Square Capital is shutting down after suffering huge losses during the retail trading frenzy earlier in the year. This marked one of the first hedge fund closures following the surge in shares of stonks.\nIn early June,AMC Entertainment Holdings Inc. and GameStop short-seller losses swelled up to$12 billionon a year-to-date basis. Both the stocks continue to seehigh interestfrom retail investors.\nPrice Action: AMC Entertainment shares closed almost 6.4% higher in Thursday’s regular trading session at $47.94, while GameStop shares closed almost 0.4% higher at $191.38.","news_type":1,"symbols_score_info":{"GME":0.9,"AMC":0.9}},"isVote":1,"tweetType":1,"viewCount":2246,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":156743989,"gmtCreate":1625238350241,"gmtModify":1703739237136,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Sobs ","listText":"<a href=\"https://laohu8.com/S/BABA\">$Alibaba(BABA)$</a>Sobs ","text":"$Alibaba(BABA)$Sobs","images":[{"img":"https://static.tigerbbs.com/b899ec0eacf287348884e35b865d69c7","width":"828","height":"1434"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/156743989","isVote":1,"tweetType":1,"viewCount":1689,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":125058705,"gmtCreate":1624637774207,"gmtModify":1703842566402,"author":{"id":"3560508329513236","authorId":"3560508329513236","name":"欣欣宇","avatar":"https://static.tigerbbs.com/9f18877cc52fe595db7dba61a107bfd4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3560508329513236","idStr":"3560508329513236"},"themes":[],"htmlText":"Wow ","listText":"Wow ","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/125058705","repostId":"2146079086","repostType":4,"isVote":1,"tweetType":1,"viewCount":564,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}